https://curecurrent.com/trials/a-combination-study-of-rucaparib-and-atezolizumab-in-participants-with-advanced-gynecologic-cancers-and-triple-negative-35001https://curecurrent.com/trials/pilot-study-of-bisphosphonates-for-breast-cancer-35002https://curecurrent.com/trials/evaluation-of-percutaneous-treatment-by-cryoablation-of-unifocal-invasive-breast-carcinoma-in-menopausal-women-with-indi-35003https://curecurrent.com/trials/efficacy-study-of-mepitel-film-the-prophylaxis-of-radiation-induced-skin-reactions-in-breast-cancer-patients-35004https://curecurrent.com/trials/hylacare-in-the-treatment-of-acute-skin-changes-in-patients-undergoing-radiotherapy-for-breast-cancer-35005https://curecurrent.com/trials/lidocaine-mucilage-icg-as-an-optical-agent-for-tumor-delineation-during-breast-conserving-surgery-35006https://curecurrent.com/trials/the-use-of-3d-surface-imaging-in-the-objective-assessment-of-breast-conserving-therapy-35007https://curecurrent.com/trials/impact-of-group-psychological-interventions-on-extracellular-vesicles-in-people-who-had-cancer-35008https://curecurrent.com/trials/study-of-activated-cytokine-induced-killer-armed-with-bispecific-antibody-for-advanced-breast-cancer-35009https://curecurrent.com/trials/fulvestrant-and-or-trastuzumab-as-first-line-therapy-in-treating-postmenopausal-women-with-stage-iv-breast-cancer-35010https://curecurrent.com/trials/exemestane-in-treating-postmenopausal-women-with-stage-iv-breast-cancer-35011https://curecurrent.com/trials/randomized-study-comparing-tamoxifen-vs-tamoxifen-aminoglutethimide-in-postmenopausal-receptor-positive-patients-35012https://curecurrent.com/trials/sorafenib-and-paclitaxel-in-treating-patients-with-metastatic-breast-cancer-35013https://curecurrent.com/trials/association-of-hepatitis-c-virus-with-breast-cancer-35014https://curecurrent.com/trials/trial-for-locally-advanced-breast-cancer-using-vorinostat-plus-chemotherapy-35015https://curecurrent.com/trials/carbon-dye-tattooing-of-biopsied-axillary-node-in-breast-cancer-35016https://curecurrent.com/trials/improving-cancer-screening-and-prevention-during-the-covid-19-pandemic-in-underserved-populations-of-rhode-island-35017https://curecurrent.com/trials/prevalence-of-paclitaxel-induced-cipn-related-pain-and-cipn-in-indian-patients-with-breast-cancer-35018https://curecurrent.com/trials/biomarker-study-of-immune-mediated-mechanism-of-action-of-neoadjuvant-trastuzumab-in-her2-breast-cancer-patients-35019https://curecurrent.com/trials/randomized-study-comparing-pre-and-postoperative-vs-conventional-adjuvant-treatment-in-receptor-negative-patients-35020https://curecurrent.com/trials/a-study-of-arry-334543-in-patients-with-advanced-cancer-35021https://curecurrent.com/trials/feasibility-of-a-clinical-trial-comparing-the-use-of-cetirizine-to-replace-diphenhydramine-in-the-prevention-of-reaction-35022https://curecurrent.com/trials/prevention-of-obesity-related-cancers-setting-up-of-a-multi-cancer-education-and-prevention-program-in-hong-kong-35023https://curecurrent.com/trials/study-of-cyp2c19-and-aldh3a1-polymorphisms-in-breast-cancer-patients-35024https://curecurrent.com/trials/safety-pharmacokinetics-and-pharmacodynamics-of-bez235-plus-mek162-in-selected-advanced-solid-tumor-patients-35025https://curecurrent.com/trials/survivorship-care-in-reducing-symptoms-in-young-adult-cancer-survivors-35026https://curecurrent.com/trials/safety-of-continuing-chemotherapy-in-overt-left-ventricular-dysfunction-using-antibodies-to-her-2-35027https://curecurrent.com/trials/the-dbcg-proton-trial-photon-versus-proton-radiation-therapy-for-early-breast-cancer-35028https://curecurrent.com/trials/evaluating-a-novel-web-based-intervention-for-breast-cancer-survivors-35029https://curecurrent.com/trials/management-radiodermatitis-in-patients-with-breast-or-head-and-neck-cancer-35030https://curecurrent.com/trials/assessing-impact-of-loco-regional-treatment-on-survival-in-metastatic-breast-cancer-at-presentation-35031https://curecurrent.com/trials/trastuzumab-and-erlotinib-as-first-line-therapy-in-treating-women-with-metastatic-breast-cancer-associated-with-her2-neu-35032https://curecurrent.com/trials/pathological-fracture-in-potentially-unstable-spinal-metastases-of-breast-cancer-35033https://curecurrent.com/trials/weekly-single-fraction-hypofractionated-adjuvant-radiotherapy-for-early-stage-breast-cancer-35034https://curecurrent.com/trials/effects-a-honey-based-syrup-on-blood-parameters-in-patients-with-breast-cancer-35035https://curecurrent.com/trials/cytokine-expression-during-radiation-for-breast-cancer-35036https://curecurrent.com/trials/effects-of-exercise-training-at-different-timeline-on-shoulder-dysfunction-after-breast-cancer-modified-radical-mastecto-35037https://curecurrent.com/trials/music-and-surgery-associated-with-relationship-and-satisfaction-35038https://curecurrent.com/trials/partial-breast-versus-no-irradiation-for-women-with-early-breast-cancer-35039https://curecurrent.com/trials/tissue-expansion-in-breast-reconstruction-without-drains-35040https://curecurrent.com/trials/physical-activity-intervention-on-myocardial-function-in-patients-with-her2-breast-cancer-35041https://curecurrent.com/trials/exercise-and-tumor-blood-flow-in-breast-cancer-patients-35042https://curecurrent.com/trials/intra-hepatic-chemotherapy-in-patient-with-non-resectable-liver-metastases-from-breast-cancer-35043https://curecurrent.com/trials/evaluation-of-magseed-as-localization-device-for-biopsy-proven-metastatic-axillary-lymph-nodes-35044https://curecurrent.com/trials/a-prospective-study-on-effect-of-systemic-adjuvant-therapy-on-cognitive-and-brain-function-of-breast-cancer-patients-35045https://curecurrent.com/trials/safety-pharmacokinetics-and-pharmacodynamics-of-bkm120-plus-mek162-in-selected-advanced-solid-tumor-patients-35046https://curecurrent.com/trials/a-study-of-gdc-0927-in-postmenopausal-women-with-locally-advanced-or-metastatic-estrogen-receptor-positive-breast-cancer-35047https://curecurrent.com/trials/her2-pet-imaging-in-breast-cancer-patients-using-68ga-aby-025-35048https://curecurrent.com/trials/evaluation-of-the-attitude-of-pre-menopausal-women-with-breast-cancer-faced-with-the-risk-of-fertility-loss-caused-by-ch-35049https://curecurrent.com/trials/combination-chemotherapy-with-or-without-colony-stimulating-factors-in-treating-women-with-breast-cancer-35050https://curecurrent.com/trials/nicotine-patches-in-reducing-hand-foot-syndrome-in-patients-who-are-receiving-capecitabine-for-metastatic-breast-cancer-35051https://curecurrent.com/trials/neurophysiological-evaluation-of-training-effect-on-cancer-related-weakness-35052https://curecurrent.com/trials/letrozole-and-metronomic-capecitabine-in-er-positive-her2-negative-advanced-breast-cancer-b-001-study-35053https://curecurrent.com/trials/project-connect-online-an-internet-based-intervention-for-women-with-breast-cancer-35054https://curecurrent.com/trials/knowledge-and-perception-of-clinical-trial-participation-in-breast-cancer-patients-in-egypt-35055https://curecurrent.com/trials/durvalumab-and-endocrine-therapy-in-er-her2-breast-cancer-after-cd8-infiltration-effective-immune-attractant-exposure-35056https://curecurrent.com/trials/open-label-phase-1b-study-of-arq-092-in-combination-with-anastrozole-35057https://curecurrent.com/trials/cosmetic-outcome-patient-reported-outcomes-and-reconstruction-related-complications-in-breast-cancer-women-treated-with-35058https://curecurrent.com/trials/cabozantinib-in-advanced-solid-malignancies-35059https://curecurrent.com/trials/validation-of-the-cps-eg-neo-bioscore-and-modified-neo-bioscore-staging-systems-after-pst-of-bc-in-china-35060https://curecurrent.com/trials/fast-mri-study-in-breast-cancer-survivors-35061https://curecurrent.com/trials/preoperative-systemic-therapy-vs-upfront-surgery-in-her2-positive-early-breast-cancer-35062https://curecurrent.com/trials/calming-alternatives-learned-during-mri-guided-breast-biopsy-35063https://curecurrent.com/trials/a-phase-ii-clinical-trial-of-pm01183-in-brca-1-2-associated-or-unselected-metastatic-breast-cancer-35064https://curecurrent.com/trials/a-study-of-pertuzumab-in-combination-with-trastuzumab-herceptin-and-a-taxane-in-first-line-treatment-in-participants-wit-35065https://curecurrent.com/trials/molecular-profiling-of-stage-ii-and-iii-breast-cancer-in-latin-american-women-receiving-standard-of-care-treatment-35066https://curecurrent.com/trials/ptx-200-paclitaxel-doxorubicin-hydrochloride-and-cyclophosphamide-in-treating-patients-with-stage-iib-iv-breast-cancer-35067https://curecurrent.com/trials/trial-of-paclitaxel-bevacizumab-and-enzastaurin-versus-paclitaxel-bevacizumab-and-placebo-for-breast-cancer-35068https://curecurrent.com/trials/neoadjuvant-herceptin-for-ductal-carcinoma-in-situ-of-the-breast-35069https://curecurrent.com/trials/effects-of-an-e-home-based-symptom-management-and-mindfulness-training-programme-on-qol-in-breast-cancer-survivors-35070https://curecurrent.com/trials/a-study-of-byl719-in-adult-patients-with-advanced-solid-malignancies-whose-tumors-have-an-alteration-of-the-pik3ca-gene-35071https://curecurrent.com/trials/the-effect-of-metformin-on-breast-cancer-patients-35072https://curecurrent.com/trials/a-phase-ii-study-to-assess-the-efficacy-and-safety-of-sc10914-in-the-metastatic-breast-cancer-patients-35073https://curecurrent.com/trials/mucoadhesive-oral-wound-rinse-in-preventing-and-treating-stomatitis-in-patients-with-er-or-pr-positive-metastatic-or-loc-35074https://curecurrent.com/trials/a-study-of-tucatinib-ont-380-combined-with-ado-trastuzumab-emtansine-t-dm1-in-patients-with-her2-breast-cancer-35075https://curecurrent.com/trials/cimer-combined-immunotherapies-in-metastatic-er-breast-cancer-35076https://curecurrent.com/trials/the-effect-of-early-versus-traditional-follow-up-on-breastfeeding-rates-at-6-months-35077https://curecurrent.com/trials/effects-of-a-physical-exercise-and-health-education-program-for-women-with-breast-cancer-undergoing-chemotherapy-35078https://curecurrent.com/trials/the-effect-of-aspirin-on-angiogenesis-proteins-in-women-on-tamoxifen-therapy-35079https://curecurrent.com/trials/the-impact-of-tamoxifen-and-aromatase-inhibitors-on-platelet-proteins-35080https://curecurrent.com/trials/a-safety-study-of-sgn-cd47m-in-patients-with-solid-tumors-35081https://curecurrent.com/trials/study-of-4-demethyl-4-cholesteryloxycarbonylpenclome-dm-choc-pen-in-patients-with-brain-tumors-35082https://curecurrent.com/trials/trial-comparing-3-schedules-of-hypofractionated-whole-breast-irradiation-in-females-with-early-stage-breast-cancer-35083https://curecurrent.com/trials/serratus-anterior-muscle-plane-block-vsthoracic-paravertebral-block-for-unilateral-mastectomies-35084https://curecurrent.com/trials/relationship-between-genetic-polymorphism-and-postoperative-nausea-and-vomiting-in-chinese-han-population-35085https://curecurrent.com/trials/trial-of-active-immunotherapy-with-globo-h-klh-opt-822-in-metastatic-breast-cancer-subjects-35086https://curecurrent.com/trials/rct-comparing-2-radiotherapy-hypofractionation-schedules-in-breast-cancer-patients-35087https://curecurrent.com/trials/phase-2-trial-of-selinexor-kpt-330-for-metastatic-triple-negative-breast-cancer-tnbc-35088https://curecurrent.com/trials/prevalence-severity-and-determinants-of-cancer-related-fatigue-crf-in-asian-breast-cancer-patients-35089https://curecurrent.com/trials/multicenter-study-of-pharmacokinetic-guided-docetaxel-in-breast-cancer-patients-receiving-docetaxel-and-cyclophosphamide-35090https://curecurrent.com/trials/efficacy-of-tramadol-with-levobupivacaine-for-modified-pectoral-nerve-block-35091https://curecurrent.com/trials/taste-disorders-and-their-relation-to-bmi-ffq-and-eortc-qlq-br23-in-breast-cancer-patients-during-chemotherapy-35092https://curecurrent.com/trials/beth-study-treatment-of-her2-positive-breast-cancer-with-chemotherapy-plus-trastuzumab-vs-chemotherapy-plus-trastuzumab-35093https://curecurrent.com/trials/tiva-admnistration-and-autologous-fat-transfer-in-breast-reconstruction-35094https://curecurrent.com/trials/safety-and-efficacy-study-of-pembrolizumab-mk-3475-in-combination-with-chemotherapy-as-neoadjuvant-treatment-for-partici-35095https://curecurrent.com/trials/prospective-pro-qol-registry-for-patients-with-bone-metastases-of-breast-or-prostate-cancer-35096https://curecurrent.com/trials/effects-of-slow-stroke-back-massage-on-crf-35097https://curecurrent.com/trials/extended-follow-up-of-columbia-mo-serum-bank-participants-35098https://curecurrent.com/trials/disposition-of-dietary-polyphenols-and-methylxanthines-in-mammary-tissues-from-breast-cancer-patients-35099https://curecurrent.com/trials/cara-treatment-pilot-study-for-breast-positioning-35100https://curecurrent.com/trials/plan-to-thrive-extending-cancer-survivorship-care-beyond-the-clinic-35101https://curecurrent.com/trials/a-study-of-vantictumab-omp-18r5-in-combination-with-paclitaxel-in-locally-recurrent-or-metastatic-breast-cancer-35102https://curecurrent.com/trials/omt-111-for-terminal-stage-solid-tumors-35103https://curecurrent.com/trials/docetaxel-and-carboplatin-with-or-without-trastuzumab-before-surgery-in-treating-women-with-locally-advanced-breast-canc-35104https://curecurrent.com/trials/establishing-technique-for-pecs2-catheter-insertion-35105https://curecurrent.com/trials/combination-of-lapatinib-with-carboplatin-paclitaxel-and-with-or-without-trastuzumab-in-metastatic-breast-cancer-35106https://curecurrent.com/trials/multi-targeted-recombinant-ad5-cea-muc1-brachyury-based-immunotherapy-vaccine-regimen-in-people-with-advanced-cancer-35107https://curecurrent.com/trials/define-the-optimal-uptake-time-of-68ga-ops202-when-used-as-a-pet-positron-emission-tomography-imaging-agent-in-subjects-35108https://curecurrent.com/trials/a-study-to-assess-preference-for-subcutaneous-trastuzumab-treatment-in-participants-with-human-epidermal-growth-factor-r-35109https://curecurrent.com/trials/diffusion-weighted-imaging-as-a-biomarker-for-detection-of-chemotherapy-induced-cardiotoxicity-35110https://curecurrent.com/trials/defining-the-her2-positive-breast-cancer-kinome-response-to-trastuzumab-pertuzumab-combination-trastuzumab-pertuzumab-or-35111https://curecurrent.com/trials/comparison-of-one-port-and-two-port-tissue-expanders-for-breast-reconstruction-35112https://curecurrent.com/trials/a-pragmatic-trial-of-ambulatory-toxicity-management-in-patients-receiving-adjuvant-or-neo-adjuvant-chemotherapy-for-earl-35113https://curecurrent.com/trials/study-of-tislelizumab-plus-chemotherapy-vs-chemotherapy-as-perioperative-treatment-in-participants-with-her2-negative-br-35114https://curecurrent.com/trials/breast-ultrasonography-and-polycystic-ovary-syndrome-35115https://curecurrent.com/trials/personalized-treatment-selection-for-metastatic-breast-cancer-35116https://curecurrent.com/trials/incidence-of-cancer-in-women-at-increased-genetic-risk-of-ovarian-cancer-35117https://curecurrent.com/trials/utilization-of-the-oncocee-platform-to-evaluate-selected-biomarker-alterations-in-ctcs-isolated-from-patients-with-mbc-35118https://curecurrent.com/trials/diagnosis-predictive-modle-for-dense-density-breast-tissue-based-on-radiomics-35119https://curecurrent.com/trials/phase-2-trial-of-seribantumab-plus-fulvestrant-in-postmenopausal-women-with-metastatic-breast-cancer-35120https://curecurrent.com/trials/defining-the-triple-negative-breast-cancer-kinome-response-to-gsk1120212-35121https://curecurrent.com/trials/improving-care-after-chemotherapy-35122https://curecurrent.com/trials/physical-activity-platform-to-improve-bone-health-in-cancer-survivors-35123https://curecurrent.com/trials/effects-of-mindfulness-meditation-and-stress-management-after-breast-cancer-35124https://curecurrent.com/trials/study-of-breast-tissue-in-women-not-previously-diagnosed-with-breast-cancer-who-are-undergoing-fine-needle-aspiration-35125https://curecurrent.com/trials/comparison-of-healthy-diets-on-breast-cancer-markers-35126https://curecurrent.com/trials/phase-iii-study-of-bkm120-placebo-with-fulvestrant-in-postmenopausal-patients-with-hormone-receptor-positive-her2-negati-35127https://curecurrent.com/trials/palbociclib-in-combination-with-fulvestrant-versus-fulvestrant-in-advanced-breast-cancer-a-real-world-study-in-china-35128https://curecurrent.com/trials/patterns-of-treatment-and-outcome-of-palbociclib-plus-endocrine-therapy-35129https://curecurrent.com/trials/musculoskeletal-pain-in-postmenopausal-early-breast-cancer-patients-receiving-aromatase-inhibitor-therapy-a-pilot-study-35130https://curecurrent.com/trials/testing-of-the-cancer-thriving-and-surviving-breast-cancer-program-35131https://curecurrent.com/trials/dexmedetomidine-or-dexmedetomidine-combined-with-dexamethasone-on-postoperative-nausea-and-vomiting-in-breast-cancer-35132https://curecurrent.com/trials/case-collection-study-for-collecting-images-for-the-development-and-validation-of-computer-aided-detection-software-35133https://curecurrent.com/trials/clinical-study-of-imaging-genomics-based-on-machine-learning-for-bcig-35134https://curecurrent.com/trials/a-randomized-controlled-trial-to-determine-the-effects-of-an-exercise-intervention-on-physical-activity-during-chemother-35135https://curecurrent.com/trials/capecitabine-and-radiation-therapy-in-treating-patients-with-nonmetastatic-breast-cancer-after-surgery-35136https://curecurrent.com/trials/presurgical-trial-of-denosumab-in-breast-cancer-35137https://curecurrent.com/trials/ixabepilone-and-sbrt-for-metastatic-breast-cancer-35138https://curecurrent.com/trials/cyberknife-partial-breast-irradiation-pbi-for-early-stage-breast-cancer-35139https://curecurrent.com/trials/durvalumab-and-tremelimumab-in-combination-with-first-line-chemotherapy-in-advanced-solid-tumors-35140https://curecurrent.com/trials/catch-up-intervention-in-increasing-cancer-screening-and-prevention-care-in-uninsured-patients-at-community-health-cente-35141https://curecurrent.com/trials/e-chec-up-scaling-up-an-efficacious-cancer-screening-intervention-for-women-with-limited-english-35142https://curecurrent.com/trials/feasibility-study-of-an-adapted-and-supported-water-polo-program-to-reduce-fatigue-related-to-cancer-and-improve-psychol-35143https://curecurrent.com/trials/everolimus-related-pneumonitis-in-mbc-35144https://curecurrent.com/trials/radiation-therapy-in-treating-patients-with-recurrent-breast-cancer-35145https://curecurrent.com/trials/a-patient-centered-continuous-and-interdisciplinary-shared-decision-making-approach-for-breast-cancer-rehabilitation-35146https://curecurrent.com/trials/can-microrna-s-predict-multicentricity-in-breast-cancer-35147https://curecurrent.com/trials/eribulin-plus-cisplatin-versus-gemcitabine-plus-cisplatin-in-triple-negative-breast-cancer-tnbc-35148https://curecurrent.com/trials/trial-evaluating-the-benefit-of-a-fitness-tracker-based-workout-during-adjuvant-radiotherapy-of-breast-cancer-35149https://curecurrent.com/trials/mr-guided-radiotherapy-to-breast-with-dose-escalation-to-regional-lymph-nodes-35150https://curecurrent.com/trials/vinorelbine-and-docetaxel-in-treating-women-with-metastatic-breast-cancer-35151https://curecurrent.com/trials/doxorubicin-hydrochloride-cyclophosphamide-and-pacltaxel-with-or-without-trastuzumab-in-treating-women-with-her2-positiv-35152https://curecurrent.com/trials/accelerated-intensity-modulated-radiation-therapy-aimrt-to-the-breast-after-segmental-mastectomy-35153https://curecurrent.com/trials/neoadjuvant-response-guided-treatment-of-her2-positive-breast-cancer-35154https://curecurrent.com/trials/post-market-study-using-the-xoft-axxent-system-35155https://curecurrent.com/trials/a-research-study-for-latina-women-after-breast-cancer-treatment-35156https://curecurrent.com/trials/quantitative-evaluation-of-the-breast-s-morphological-variations-during-radiotherapy-morphobreast3d-35157https://curecurrent.com/trials/anti-pd-l1-antibody-anti-ctla-4-antibody-in-combination-with-hormone-therapy-in-patients-with-hormone-receptor-positive-35158https://curecurrent.com/trials/end-of-life-care-for-african-americans-35159https://curecurrent.com/trials/study-of-bms-754807-combined-with-letrozole-or-bms-754807-alone-in-patients-with-hormone-receptor-positive-breast-cancer-35160https://curecurrent.com/trials/characterization-comparison-of-drugable-mutations-in-primary-and-metastatic-tumors-ctcs-and-cfdna-in-mbcpatients-35161https://curecurrent.com/trials/maintenance-treatment-with-eribulin-mesylate-versus-observation-in-triple-negative-breast-cancer-patients-35162https://curecurrent.com/trials/study-of-ttc-352-in-patients-with-metastatic-breast-cancer-progressing-on-endocrine-therapy-35163https://curecurrent.com/trials/cpr-prediction-after-neoadjuvant-using-excisional-biopsy-by-radiofrequency-in-breast-cancer-from-ii-iii-uicc-stages-35164https://curecurrent.com/trials/immediate-implant-breast-reconstruction-35165https://curecurrent.com/trials/implementation-and-evaluation-of-a-social-journey-accompanied-in-breast-cancer-diagnosis-epars-sein-35166https://curecurrent.com/trials/added-conversational-hypnosis-reduced-general-anesthesia-side-effects-for-day-case-breast-surgery-35167https://curecurrent.com/trials/hypnosis-for-patients-treated-with-adjuvant-chemotherapy-for-breast-cancer-hypnoval-35168https://curecurrent.com/trials/enzastaurin-in-combination-of-capecitabine-to-treat-breast-cancer-35169https://curecurrent.com/trials/a-study-of-fluzoparib-apatinib-versus-chemotherapy-treatment-of-physician-s-choice-in-her2-negative-metastatic-breast-ca-35170https://curecurrent.com/trials/study-of-radium-223-dichloride-versus-placebo-and-hormonal-treatment-as-background-therapy-in-subjects-with-bone-predomi-35171https://curecurrent.com/trials/evaluation-of-the-efficacy-of-digital-breast-tomosynthesis-imaging-35172https://curecurrent.com/trials/nanoparticle-based-paclitaxel-vs-solvent-based-paclitaxel-as-part-of-neoadjuvant-chemotherapy-for-early-breast-cancer-ge-35173https://curecurrent.com/trials/study-comparing-whole-breast-radiotherapy-with-a-daily-versus-a-weekly-tumor-35174https://curecurrent.com/trials/mechanistic-study-of-duloxetine-in-breast-cancer-patients-with-chronic-pain-35175https://curecurrent.com/trials/docetaxel-with-bevacizumab-as-first-line-therapy-in-treating-women-with-stage-iv-breast-cancer-35176https://curecurrent.com/trials/gene-expression-after-regional-or-general-anesthesia-in-patients-undergoing-breast-cancer-surgery-35177https://curecurrent.com/trials/durvalumab-and-eribulin-in-her2-negative-metastatic-breast-cancer-and-recurrent-ovarian-cancer-35178https://curecurrent.com/trials/at-versus-tp-as-neoadjuvant-chemotherapy-in-patients-with-her2-negative-early-breast-cancer-35179https://curecurrent.com/trials/genomic-signatures-to-predict-treatment-response-35180https://curecurrent.com/trials/a-prospective-cohort-study-of-occupational-exposures-and-cancer-risk-among-women-35181https://curecurrent.com/trials/study-of-the-effects-of-cyclodynon-on-reducing-the-cumulative-risk-of-breast-cancer-development-in-a-female-aged-40-52-35182https://curecurrent.com/trials/99mtc-3prgd2-spect-ct-in-breast-cancer-patients-35183https://curecurrent.com/trials/paclitaxel-trastuzumab-and-pertuzumab-in-the-treatment-of-metastatic-her2-positive-breast-cancer-35184https://curecurrent.com/trials/gw572016-and-trastuzumab-in-treating-patients-with-metastatic-breast-cancer-that-overexpresses-her2-neu-35185https://curecurrent.com/trials/voriconazole-compared-with-itraconazole-in-preventing-fungal-infections-in-patients-undergoing-allogeneic-hematopoietic-35186https://curecurrent.com/trials/preoperative-use-of-tocotrienol-from-annatto-bixa-orellana-l-in-breast-cancer-patients-a-prospective-clinical-trial-35187https://curecurrent.com/trials/cp-724-714-in-treating-patients-with-metastatic-breast-cancer-35188https://curecurrent.com/trials/docetaxel-and-trastuzumab-with-or-without-carboplatin-in-treating-women-with-her2-positive-breast-cancer-35189https://curecurrent.com/trials/vaccine-therapy-in-treating-women-with-previously-treated-metastatic-breast-cancer-35190https://curecurrent.com/trials/infliximab-in-treating-cancer-related-fatigue-in-postmenopausal-women-who-have-undergone-treatment-for-breast-cancer-35191https://curecurrent.com/trials/effect-of-intravaginal-prasterone-on-symptoms-of-vva-in-women-under-treatment-with-an-aromatase-inhibitor-for-breast-can-35192https://curecurrent.com/trials/intermittent-g-csf-in-patients-with-breast-cancer-receiving-adjuvant-docetaxel-doxorubicin-and-cyclophosphamide-tac-35193https://curecurrent.com/trials/bimatoprost-ophthalmic-solution-in-increasing-eyebrow-and-eyelash-growth-in-patients-who-have-undergone-chemotherapy-for-35194https://curecurrent.com/trials/study-of-gnrh-a-leuprorelin-lorelin-depot-plus-leterozole-everolimus-for-premenopausal-women-with-metastatic-breast-canc-35195https://curecurrent.com/trials/prospective-breast-cancer-biobanking-35196https://curecurrent.com/trials/treatment-of-brain-metastases-from-breast-cancer-with-eribulin-mesylate-35197https://curecurrent.com/trials/study-of-esr1-mutations-in-metastatic-breast-cancer-35198https://curecurrent.com/trials/anlotinib-in-metastatic-her2-negative-breast-cancer-35199https://curecurrent.com/trials/paclitaxel-and-carboplatin-in-treating-patients-with-metastatic-or-recurrent-solid-tumors-and-hiv-infection-35200https://curecurrent.com/trials/evaluating-new-surgical-technique-in-management-of-female-patients-with-operable-multifocal-breast-cancer-35201https://curecurrent.com/trials/evaluating-the-impact-of-baduanjin-exercise-intervention-on-quality-of-life-in-breast-cancer-survivors-receiving-aromata-35202https://curecurrent.com/trials/naf-pet-mri-evaluation-for-bone-metastases-in-breast-cancer-35203https://curecurrent.com/trials/young-and-strong-an-education-and-supportive-care-intervention-study-for-young-women-with-breast-cancer-35204https://curecurrent.com/trials/eras-in-autologous-breast-reconstruction-a-pilot-rct-35205https://curecurrent.com/trials/implementing-a-decision-aid-for-breast-cancer-and-dcis-patients-deciding-on-their-radiation-treatment-35206https://curecurrent.com/trials/taxotere-and-adriamycin-cytoxan-ac-validation-in-breast-cancer-patients-35207https://curecurrent.com/trials/sentinel-lymph-node-biopsy-findings-in-patients-with-breast-cancer-35208https://curecurrent.com/trials/tch-versus-ec-th-as-neoadjuvant-treatment-for-her2-positive-breast-cancer-35209https://curecurrent.com/trials/whole-breast-irradiation-vs-twice-daily-vs-once-daily-accelerated-partial-breast-irradiation-35210https://curecurrent.com/trials/assessment-of-outpatient-digital-follow-up-of-patients-over-70-years-of-age-undergoing-chemotherapy-treatment-35211https://curecurrent.com/trials/efficacy-of-mbsr-treatment-of-cognitive-impairment-among-breast-cancer-survivors-35212https://curecurrent.com/trials/arimidex-with-or-without-faslodex-in-postmenopausal-women-with-hr-positive-breast-cancer-35213https://curecurrent.com/trials/docetaxel-carboplatin-trastuzumab-and-bevacizumab-for-breast-cancer-and-bone-marrow-micrometastases-35214https://curecurrent.com/trials/older-patients-with-newly-diagnosed-breast-cancer-or-colon-cancer-35215https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-antitumor-activity-of-fcn-437c-35216https://curecurrent.com/trials/resistance-training-to-improve-fatigue-and-physical-function-in-postmenopausal-breast-cancer-survivors-35217https://curecurrent.com/trials/post-mastectomy-analgesia-using-exparel-liposomal-versus-standard-bupivacaine-or-placebo-35218https://curecurrent.com/trials/vinorelbine-and-celecoxib-in-treating-women-with-relapsed-or-metastatic-breast-cancer-35219https://curecurrent.com/trials/radiation-therapy-after-lumpectomy-in-treating-women-with-ductal-carcinoma-in-situ-or-invasive-breast-cancer-35220https://curecurrent.com/trials/epirubicin-in-treating-women-who-are-undergoing-surgery-for-stage-i-stage-ii-or-stage-iii-breast-cancer-35221https://curecurrent.com/trials/radiofrequency-identification-technology-in-locating-non-palpable-breast-lesions-in-patients-undergoing-surgery-35222https://curecurrent.com/trials/kindness-interventions-in-enhancing-well-being-in-breast-cancer-survivors-35223https://curecurrent.com/trials/exemestane-with-sunitinib-sutent-in-metastatic-breast-cancer-35224https://curecurrent.com/trials/eribulin-mesylate-in-treating-patients-with-previously-treated-metastatic-breast-cancer-35225https://curecurrent.com/trials/capecitabine-maintenance-therapy-following-capecitabine-combined-with-docetaxel-in-treatment-of-mbc-35226https://curecurrent.com/trials/bupivacaine-versus-liposomal-bupivacaine-for-breast-pain-management-after-breast-recontruction-35227https://curecurrent.com/trials/s-equol-in-women-with-triple-negative-breast-cancer-35228https://curecurrent.com/trials/primary-progesterone-therapy-for-operable-breast-cancer-35229https://curecurrent.com/trials/trastuzumab-combined-with-pyrrolidine-and-chemotherapy-for-locally-her2-positive-breast-cancer-35230https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-camrelizumab-plus-radiotherapy-for-patients-with-early-triple-negative-breast-35231https://curecurrent.com/trials/breast-density-measurements-in-digital-mammography-and-breast-tomosynthesis-systems-of-different-pixel-size-35232https://curecurrent.com/trials/cancer-survivor-registry-the-breast-cancer-m-a-p-mind-affects-the-physical-project-35233https://curecurrent.com/trials/effects-of-training-and-detraining-on-postmenopausal-breast-cancer-survivors-35234https://curecurrent.com/trials/perioperative-analgesic-modalities-for-breast-cancer-surgeries-35235https://curecurrent.com/trials/telenursing-and-breast-cancer-the-turkish-case-35236https://curecurrent.com/trials/a-study-of-dc-cik-immunotherapy-in-the-treatment-of-solid-tumors-35237https://curecurrent.com/trials/phase-ib-ii-study-of-plx-3397-and-eribulin-in-patients-with-metastatic-breast-cancer-35238https://curecurrent.com/trials/diagnosis-and-prediction-of-taxanes-induced-cardiac-dysfunction-35239https://curecurrent.com/trials/food-supplements-based-on-nettle-and-peppermint-to-control-signs-and-symptoms-induced-by-cancer-therapies-35240https://curecurrent.com/trials/guide-for-prioritisation-of-patients-for-referral-to-breast-clinics-35241https://curecurrent.com/trials/ipilimumab-and-nivolumab-in-treating-patients-with-recurrent-stage-iv-her2-negative-inflammatory-breast-cancer-35242https://curecurrent.com/trials/chimeric-antigen-receptor-modified-t-cells-for-breast-cancer-35243https://curecurrent.com/trials/neoadjuvant-study-of-abemaciclib-durvalumab-and-an-aromatase-inhibitor-early-stage-breast-cancer-35244https://curecurrent.com/trials/robotic-versus-conventional-or-endoscopic-nipple-sparing-mastectomy-for-breast-cancer-35245https://curecurrent.com/trials/trastuzumab-combined-with-chemotherapy-or-endocrine-therapy-to-treat-metastatic-luminal-b2-breast-cancer-35246https://curecurrent.com/trials/neo-adjuvant-treatment-with-palbociclib-effect-on-ki67-and-apoptosis-before-during-and-after-treatment-35247https://curecurrent.com/trials/testing-video-information-about-mammography-screening-35248https://curecurrent.com/trials/a-multi-center-study-of-lapatinib-in-patients-with-trastuzumab-refractory-metastatic-breast-cancer-35249https://curecurrent.com/trials/simultaneous-integrated-boost-with-volumetric-arc-radiotherapy-in-patients-with-breast-cancer-35250https://curecurrent.com/trials/cognutrin-in-breast-cancer-survivors-35251https://curecurrent.com/trials/2nd-line-treatment-with-pemetrexed-and-sorafenib-for-recurrent-or-metastatic-triple-negative-breast-cancer-35252https://curecurrent.com/trials/repeated-bone-marrow-transplantation-in-treating-women-with-advanced-breast-cancer-35253https://curecurrent.com/trials/eribulin-plus-gemcitabine-eg-vs-paclitaxel-plus-gemcitabine-pg-in-her2-negative-metastatic-breast-cancer-35254https://curecurrent.com/trials/study-of-health-effects-of-cosmetic-breast-augmentation-35255https://curecurrent.com/trials/role-of-abus-as-an-alternative-to-breast-mri-in-assessing-response-to-neoadjuvant-chemotherapy-35256https://curecurrent.com/trials/pembrolizumab-and-capecitabine-in-treating-patients-with-locally-advanced-or-metastatic-triple-negative-or-hormone-refra-35257https://curecurrent.com/trials/study-of-eribulin-mesylate-in-combination-with-pegylated-recombinant-human-hyaluronidase-pegph20-versus-eribulin-mesylat-35258https://curecurrent.com/trials/safety-and-efficiency-of-t-cell-against-breast-cancer-35259https://curecurrent.com/trials/sentinel-node-biopsy-vs-observation-after-axillary-pet-35260https://curecurrent.com/trials/pilot-usability-and-feasibility-testing-on-kinect-enhanced-training-system-for-lymphatic-exercises-35261https://curecurrent.com/trials/primary-breast-cancer-occurring-concomitant-with-pregnancy-35262https://curecurrent.com/trials/surgical-trial-to-evaluate-the-impact-of-a-lymphoscintigraphy-prior-to-sentinel-node-biopsy-in-early-breast-cancer-35263https://curecurrent.com/trials/a-comparative-study-of-mammography-and-ultrasound-for-breast-cancer-screening-and-early-diagnosis-35264https://curecurrent.com/trials/effect-of-vitamin-c-and-e-in-breast-cancer-patients-undergoing-chemotherapy-35265https://curecurrent.com/trials/phase-study-of-pegylated-liposomal-doxorubicin-pld-plus-trastuzumab-in-her-2-positive-metastatic-breast-cancer-35266https://curecurrent.com/trials/a-bioequivalence-study-of-doxorubicin-hydrochloride-liposome-injection-35267https://curecurrent.com/trials/reversing-hormone-resistance-in-advanced-breast-cancer-with-pazopanib-35268https://curecurrent.com/trials/guided-imagery-music-in-cancer-35269https://curecurrent.com/trials/pegylated-liposomal-doxorubicin-or-epirubicin-in-neoadjuvant-or-adjuvant-chemotherapy-for-breast-cancer-35270https://curecurrent.com/trials/locoregional-surgery-of-the-primary-tumor-in-de-novo-stage-iv-breast-cancer-patients-35271https://curecurrent.com/trials/implementing-systematic-distress-screening-in-breast-cancer-35272https://curecurrent.com/trials/patient-derived-xenograft-pdx-modeling-of-treatment-response-for-triple-negative-breast-cancer-35273https://curecurrent.com/trials/neoadjuvant-response-guided-treatment-of-slowly-proliferating-hormone-receptor-positive-tumors-35274https://curecurrent.com/trials/a-multi-reader-multi-case-pivotal-trial-35275https://curecurrent.com/trials/study-of-safety-and-efficacy-of-durvalumab-in-combination-with-paclitaxel-in-metastatic-triple-negative-breast-cancer-pa-35276https://curecurrent.com/trials/a-phase-ii-single-arm-trial-of-poziotinib-as-salvage-treatment-in-patients-with-metastatic-breast-cancer-who-has-her2-or-35277https://curecurrent.com/trials/reversing-therapy-resistance-with-epigenetic-immune-modification-35278https://curecurrent.com/trials/mindful-life-mindfulness-based-intervention-vs-cognitive-behavioral-therapy-in-patients-with-breast-cancer-35279https://curecurrent.com/trials/objective-assessment-of-physical-activity-during-chemotherapy-for-breast-cancer-35280https://curecurrent.com/trials/the-risk-of-postoperative-wound-complications-following-the-use-of-negative-pressure-wound-therapy-in-patients-undergoin-35281https://curecurrent.com/trials/safety-and-immunogenicity-of-a-personalized-polyepitope-dna-vaccine-strategy-in-breast-cancer-patients-with-persistent-t-35282https://curecurrent.com/trials/genetic-predisposition-to-breast-and-ovarian-cancer-prospective-study-of-brcax-gene-mutation-35283https://curecurrent.com/trials/utilizing-multiomic-advanced-diagnostics-to-identify-cdk-4-6-inhibitor-response-predictors-and-a-post-treatment-multiomi-35284https://curecurrent.com/trials/night-time-compression-systems-for-breast-cancer-related-lymphedema-35285https://curecurrent.com/trials/improving-surgical-decision-making-in-young-women-with-breast-cancer-35286https://curecurrent.com/trials/mri-radiomics-assessing-neoadjuvant-chemotherapy-in-breast-cancer-to-predict-lymph-node-metastasis-and-prognosis-rbc-02-35287https://curecurrent.com/trials/sms-reminders-to-improve-medication-adherence-of-aromatase-inhibitors-35288https://curecurrent.com/trials/byl719-t-dm1-in-her2-metastatic-breast-cancer-pts-who-progress-on-prior-trastuzumab-taxane-tx-35289https://curecurrent.com/trials/intercostobrachial-nerve-sparing-to-reduce-post-surgical-pain-35290https://curecurrent.com/trials/examining-patient-preferences-about-the-ibm-watson-oncology-clinical-decision-support-system-35291https://curecurrent.com/trials/oxidative-stress-anxiety-and-depression-in-breast-cancer-patients-impact-of-music-therapy-35292https://curecurrent.com/trials/shave-margins-in-breast-conservation-therapy-35293https://curecurrent.com/trials/evaluation-and-modeling-of-the-g-csf-effect-on-the-evolution-of-neutrophils-during-chemotherapy-based-on-eribulin-35294https://curecurrent.com/trials/a-study-of-fluvestrant-combined-with-oral-vinorelbine-in-hormone-receptor-positive-advanced-breast-cancer-35295https://curecurrent.com/trials/a-study-to-assess-the-safety-and-efficacy-of-the-vegfr-fgfr-pdgfr-inhibitor-lucitanib-given-to-patients-with-metastatic-35296https://curecurrent.com/trials/european-celecoxib-trial-in-primary-breast-cancer-35297https://curecurrent.com/trials/antler-plate-on-preventing-mammary-high-risk-lesions-from-malignant-development-35298https://curecurrent.com/trials/using-pranayama-and-deep-breathing-exercises-to-reduce-cancer-related-fatigue-and-insomnia-during-radiotherapy-35299https://curecurrent.com/trials/5-element-music-therapy-on-patients-with-breast-cancer-35300https://curecurrent.com/trials/cytokine-profiles-in-breast-cancer-patients-undergoing-chemotherapy-35301https://curecurrent.com/trials/sentinel-node-biopsy-alone-or-with-axillary-dissection-after-primary-chemotherapy-35302https://curecurrent.com/trials/exemestane-rad001-metformin-35303https://curecurrent.com/trials/abrogation-of-chronic-monoclonal-antibody-treatment-induced-t-cell-exhaustion-with-durvalumab-in-advanced-her-2-negative-35304https://curecurrent.com/trials/fujifilm-dbt-plus-s-view-versus-ffdm-alone-in-the-detection-of-breast-cancer-35305https://curecurrent.com/trials/adjuvant-chemotherapy-for-triple-negative-breast-cancer-patients-with-residual-disease-after-neoadjuvant-chemotherapy-35306https://curecurrent.com/trials/e7389-versus-capecitabine-in-patients-with-locally-advanced-or-metastatic-breast-cancer-previously-treated-with-anthracy-35307https://curecurrent.com/trials/pyrotinib-plus-capecitabine-versus-lapatinib-plus-capecitabine-in-patients-with-her2-metastatic-breast-cancer-phoebe-35308https://curecurrent.com/trials/a-neoadjuvant-study-of-abemaciclib-ly2835219-in-postmenopausal-women-with-hormone-receptor-positive-her2-negative-breast-35309https://curecurrent.com/trials/ketotifen-as-a-cardioprotective-agent-in-breast-cancer-patients-receiving-anthracycline-containing-chemotherapy-35310https://curecurrent.com/trials/feasibility-of-integrating-the-outcomes4me-smartphone-navigation-application-into-the-care-management-of-breast-cancer-p-35311https://curecurrent.com/trials/regional-anesthesia-and-breast-cancer-recurrence-35312https://curecurrent.com/trials/pet-mr-in-surgical-planning-for-breast-ca-treated-with-neoadj-chemo-35313https://curecurrent.com/trials/health-related-quality-of-life-intervention-in-survivors-of-breast-and-other-cancers-experiencing-cancer-related-fatigue-35314https://curecurrent.com/trials/evaluation-of-the-cardioprotective-effect-of-l-carnitine-and-silymarin-in-patients-receiving-anthracycline-chemotherapy-35315https://curecurrent.com/trials/strain-vs-left-ventricular-ejection-fraction-based-cardiotoxicity-prevention-in-breast-cancer-35316https://curecurrent.com/trials/neoadjuvant-carboplatin-weekly-abraxane-and-trastuzumab-in-her2-breast-cancer-35317https://curecurrent.com/trials/a-study-of-trifluridine-tipiracil-in-triple-negative-metastatic-breast-cancer-35318https://curecurrent.com/trials/sbrt-for-breast-cancer-oligometastases-35319https://curecurrent.com/trials/complementary-and-alternative-medicine-on-mental-health-in-breast-cancer-patients-35320https://curecurrent.com/trials/a-prospective-cohort-study-comparing-disparity-in-surgical-procedure-wide-local-excision-only-vs-any-other-surgery-proce-35321https://curecurrent.com/trials/neoadjuvant-chemotherapy-with-or-without-metformin-in-early-breast-cancer-35322https://curecurrent.com/trials/a-study-of-ly3381916-alone-or-in-combination-with-ly3300054-in-participants-with-solid-tumors-35323https://curecurrent.com/trials/safety-and-efficacy-of-p53-gene-therapy-combined-with-immune-checkpoint-inhibitors-in-solid-tumors-35324https://curecurrent.com/trials/pharmacokinetic-and-safety-comparison-of-two-capecitabine-tablets-in-patients-with-colorectal-or-breast-cancer-35325https://curecurrent.com/trials/capsular-contracture-after-pmrt-using-prepectoral-versus-subpectoral-implant-based-breast-reconstruction-preper-trial-35326https://curecurrent.com/trials/simvastatin-effect-in-combination-with-neoadjuvant-chemotherapy-to-clinical-response-and-tumor-free-margin-in-locally-ad-35327https://curecurrent.com/trials/a-dose-escalation-study-of-arx788-iv-administered-in-subjects-with-advanced-cancers-with-her2-expression-35328https://curecurrent.com/trials/reach-for-health-study-obesity-related-mechanisms-and-mortality-in-breast-cancer-survivors-35329https://curecurrent.com/trials/early-detection-of-lymphedema-with-bio-electrical-impedance-analysis-in-patients-after-breast-cancer-surgery-35330https://curecurrent.com/trials/compression-bandages-in-upper-limb-lymphedema-35331https://curecurrent.com/trials/a-trial-evaluating-the-efficacy-of-metastasectomy-in-patients-with-oligo-metastatic-breast-cancer-omit-35332https://curecurrent.com/trials/a-study-of-tucatinib-ont-380-combined-with-capecitabine-and-or-trastuzumab-in-patients-with-her2-metastatic-breast-cance-35333https://curecurrent.com/trials/study-of-medi-573-plus-standard-endocrine-therapy-for-women-with-hormone-sensitive-metastatic-breast-cancer-35334https://curecurrent.com/trials/sentinel-lymph-node-biopsy-with-or-without-para-sentinel-lymph-node-dissection-in-breast-cancer-35335https://curecurrent.com/trials/imaging-study-for-fdcyd-and-thu-cancer-treatment-35336https://curecurrent.com/trials/early-interim-18f-fdg-pet-and-18f-flt-pet-for-predicting-treatment-response-and-survival-in-metastatic-breast-cancer-35337https://curecurrent.com/trials/study-to-evaluate-the-safety-and-tolerability-of-andecaliximab-as-monotherapy-and-in-combination-with-chemotherapy-in-pa-35338https://curecurrent.com/trials/treatment-of-breast-cancer-related-lymphedema-with-cell-assisted-lipotransfer-35339https://curecurrent.com/trials/to-assess-the-bioavailability-and-safety-of-paclitaxel-injection-concentrate-for-suspension-in-subjects-with-locally-rec-35340https://curecurrent.com/trials/a-study-of-ly3295668-erbumine-in-participants-with-breast-cancer-that-has-spread-to-other-parts-of-the-body-35341https://curecurrent.com/trials/evaluating-the-clinical-value-of-traditional-chinese-medicine-in-the-adjuvant-therapy-of-triple-negative-breast-cancer-35342https://curecurrent.com/trials/a-study-to-assess-the-safety-and-the-efficacy-of-iv-fosnetupitant-palonosetron-260-mg-0-25-mg-combination-compared-to-or-35343https://curecurrent.com/trials/estrogen-receptor-positive-breast-cancer-patient-derived-xenografts-35344https://curecurrent.com/trials/azd8186-first-time-in-patient-ascending-dose-study-35345https://curecurrent.com/trials/minimal-invasive-breast-cancer-excision-using-the-breast-lesion-excision-system-under-ultrasound-guidance-35346https://curecurrent.com/trials/the-frequency-of-thyroid-diseases-in-women-with-breast-cancer-35347https://curecurrent.com/trials/study-of-chemotherapy-in-combination-with-ido-inhibitor-in-metastatic-breast-cancer-35348https://curecurrent.com/trials/ido-inhibitor-study-for-relapsed-or-refractory-solid-tumors-35349https://curecurrent.com/trials/a-companion-sample-collection-protocol-to-support-the-discovery-of-breast-cancer-aberrations-with-treatment-of-cdk4-6-th-35350https://curecurrent.com/trials/real-time-interactive-digital-healthcare-system-in-post-operation-patients-with-breast-cancer-pilot-study-35351https://curecurrent.com/trials/vaccine-treatment-for-advanced-breast-cancer-35352https://curecurrent.com/trials/a-study-of-tqb2450-injection-combined-with-anlotinib-hydrochloride-capsule-versus-paclitaxel-for-injection-albumin-bound-35353https://curecurrent.com/trials/study-of-crlx101-nlg207-in-the-treatment-of-advanced-solid-tumors-35354https://curecurrent.com/trials/a-trial-to-strengthen-existential-resiliency-among-women-with-metastatic-breast-cancer-35355https://curecurrent.com/trials/granulocyte-colony-stimulating-factors-or-antibiotics-for-primary-prophylaxis-for-febrile-neutropenia-35356https://curecurrent.com/trials/intestine-bacteria-and-breast-cancer-risk-35357https://curecurrent.com/trials/biopsy-scanner-lltech-technology-for-diagnosis-of-breast-cancer-35358https://curecurrent.com/trials/efficacy-of-capecitabine-metronomic-chemotherapy-to-triple-negative-breast-cancer-35359https://curecurrent.com/trials/enumeration-and-molecular-characterization-of-circulating-tumour-cells-in-women-with-metastatic-breast-cancer-35360https://curecurrent.com/trials/breast-reconstruction-outcomes-with-and-without-strattice-35361https://curecurrent.com/trials/a-phase-1b-2-study-of-serabelisib-in-combination-with-canagliflozin-in-patients-with-advanced-solid-tumors-35362https://curecurrent.com/trials/diagnostic-contribution-of-ultrasonography-in-breast-cancer-related-lymphedema-35363https://curecurrent.com/trials/unidas-por-vida-y-salud-increasing-breast-and-cervical-cancer-screening-in-el-paso-35364https://curecurrent.com/trials/engineering-gut-microbiome-to-target-breast-cancer-35365https://curecurrent.com/trials/simulated-screening-study-for-breast-imaging-35366https://curecurrent.com/trials/the-effect-of-nitroglycerin-ointment-fluorescent-angiography-and-incisional-negative-pressure-wound-therapy-on-mastectom-35367https://curecurrent.com/trials/acquisition-of-breast-mammography-images-35368https://curecurrent.com/trials/international-breast-cancer-biomarker-standard-of-care-and-real-world-outcomes-study-35369https://curecurrent.com/trials/adjuvant-platinum-and-taxane-in-triple-negative-breast-cancer-pattern-35370https://curecurrent.com/trials/pyrotinib-or-trastuzumab-plus-nab-paclitaxel-as-neoadjuvant-therapy-in-her2-positive-breast-cancer-35371https://curecurrent.com/trials/minus-anthracycline-or-short-term-versus-epirubicin-and-cyclophosphamide-followed-by-paclitaxel-regimen-for-adjuvant-bre-35372https://curecurrent.com/trials/mindfulness-for-breast-cancer-35373https://curecurrent.com/trials/relationship-between-body-composition-food-consumption-and-micro-and-macronutrients-with-gene-expression-in-breast-cance-35374https://curecurrent.com/trials/an-optical-assay-system-for-intra-operative-assessment-of-tumor-margins-in-patients-35375https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-the-combination-of-tq-b211-plus-docetaxel-in-patients-with-her2-positive-35376https://curecurrent.com/trials/study-of-the-effectiveness-of-supervised-vs-non-supervised-therapeutic-exercise-in-cancer-patients-35377https://curecurrent.com/trials/intrapleural-bg00001-in-treating-patients-with-malignant-pleural-mesothelioma-or-malignant-pleural-effusions-35378https://curecurrent.com/trials/molecular-breast-imaging-in-screening-breast-cancer-35379https://curecurrent.com/trials/study-on-the-adverse-drug-reactions-adrs-of-apatinib-and-their-biomarker-correlations-35380https://curecurrent.com/trials/radical-local-vs-palliative-therapy-for-breast-cancer-patientts-with-ipsilateral-humerus-or-sternum-oligometastasis-35381https://curecurrent.com/trials/bioequivalence-food-effect-study-in-patients-with-solid-tumor-or-hematologic-malignancies-35382https://curecurrent.com/trials/the-effect-of-topical-tranexamic-acid-on-bleeding-and-seroma-formation-in-after-undergoing-mastectomy-35383https://curecurrent.com/trials/a-randomized-trial-comparing-ec-wpversus-ep-wp-as-adjuvant-therapy-for-operable-breast-cancer-patients-less-than-40-year-35384https://curecurrent.com/trials/a-study-of-her2-breast-cancer-patients-with-active-brain-metastases-treated-with-afatinib-t-dm1-vs-t-dm1-alone-35385https://curecurrent.com/trials/zoledronate-in-treating-bone-marrow-micrometastases-in-women-with-stage-i-stage-ii-or-stage-iii-breast-cancer-35386https://curecurrent.com/trials/test-retest-reproducibility-of-18f-fluoroestradiol-fes-pet-35387https://curecurrent.com/trials/long-term-use-of-savi-scout-pilot-study-35388https://curecurrent.com/trials/comparison-of-the-philips-microdose-tomosynthesis-system-to-2d-digital-mammography-35389https://curecurrent.com/trials/pilot-study-of-a-breast-cancer-vaccine-plus-poly-iclc-for-breast-cancer-35390https://curecurrent.com/trials/biomarkers-in-tissue-samples-from-patients-with-newly-diagnosed-breast-cancer-treated-with-zoledronic-acid-35391https://curecurrent.com/trials/eribulin-in-brain-metastases-from-her2-negative-breast-cancer-35392https://curecurrent.com/trials/pf-06671008-dose-escalation-study-in-advanced-solid-tumors-35393https://curecurrent.com/trials/cancer-screening-and-prevention-program-for-high-risk-women-35394https://curecurrent.com/trials/behavioral-weight-and-symptom-management-for-breast-cancer-survivors-and-partners-35395https://curecurrent.com/trials/effectiveness-of-taping-on-anastomotic-regions-in-patients-with-breast-cancer-related-lymphoedema-35396https://curecurrent.com/trials/cancer-and-other-disease-risks-in-u-s-nuclear-medicine-technologists-35397https://curecurrent.com/trials/markers-to-evaluate-the-efficacy-of-ph-based-regimen-as-a-neoadjuvant-therapy-for-operable-her2-positive-breast-cancer-35398https://curecurrent.com/trials/targeted-pain-coping-skills-training-pcst-for-prevention-and-treatment-of-persistent-post-mastectomy-pain-35399https://curecurrent.com/trials/breast-cancer-breast-disease-and-pesticides-35400https://curecurrent.com/trials/ultrasound-guided-costotransverse-block-for-breast-cancer-surgery-35401https://curecurrent.com/trials/impact-of-physical-activity-on-biomarker-of-aging-and-body-composition-among-breast-cancer-survivors-age-65-and-older-35402https://curecurrent.com/trials/lymph-node-removal-in-treating-women-who-have-stage-i-or-stage-iia-breast-cancer-35403https://curecurrent.com/trials/studying-normal-breast-tissue-and-cancer-risk-35404https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-breast-cancer-35405https://curecurrent.com/trials/cohort-study-of-patients-with-her2-negative-mbc-and-brca-1-2-pathogenic-mutation-35406https://curecurrent.com/trials/gedatolisib-hydroxychloroquine-or-the-combination-for-prevention-of-recurrent-breast-cancer-glacier-35407https://curecurrent.com/trials/molecular-profiling-after-neoadjuvant-chemotherapy-for-triple-negative-breast-cancer-35408https://curecurrent.com/trials/real-world-study-of-pyrotinib-in-human-epidermal-growth-factor-receptor-2-her2-positive-breast-cancer-35409https://curecurrent.com/trials/study-comparing-paclitaxel-plus-carboplatin-versus-anthracyclines-followed-by-docetaxel-as-adjuvant-chemotherapy-for-tri-35410https://curecurrent.com/trials/examining-and-comparing-the-temporal-changes-and-results-of-cosmetic-quality-of-life-and-patient-satisfaction-achieved-w-35411https://curecurrent.com/trials/predictors-of-ovarian-insufficiency-in-young-breast-cancer-patients-35412https://curecurrent.com/trials/trastuzumab-cyclophosphamide-and-an-allogeneic-gm-csf-secreting-breast-tumor-vaccine-for-the-treatment-of-her-2-neu-over-35413https://curecurrent.com/trials/cancer-related-cognitive-impairment-after-chemotherapy-evaluation-of-potential-therapeutic-interventions-35414https://curecurrent.com/trials/a-study-of-tq-b3525-tablets-combined-with-fulvestrant-injection-in-subjects-with-hr-positive-her2-negative-and-pik3ca-mu-35415https://curecurrent.com/trials/comparison-of-the-cosmetic-results-quality-of-life-and-patient-satisfaction-achieved-with-round-block-and-retroglandular-35416https://curecurrent.com/trials/examining-the-cosmetic-results-quality-of-life-and-patient-satisfaction-achieved-with-skin-reducing-nipple-sparing-maste-35417https://curecurrent.com/trials/a-feasibility-study-for-women-receiving-anthracycline-chemotherapy-with-or-without-radiation-for-her2-neu-positive-invas-35418https://curecurrent.com/trials/reproductive-health-survivorship-care-plan-pilot-35419https://curecurrent.com/trials/the-ghana-breast-health-study-35420https://curecurrent.com/trials/high-risk-er-her2-t1-2n0-1-early-breast-cancer-with-palbociclib-plus-endocrine-therapy-hipex-35421https://curecurrent.com/trials/reproductive-health-survivorship-care-plan-35422https://curecurrent.com/trials/breast-cancer-in-poland-an-expanded-study-to-assess-occupational-and-environmental-factors-and-interactions-with-genetic-35423https://curecurrent.com/trials/combined-mri-and-optical-imaging-to-improved-breast-cancer-diagnosis-35424https://curecurrent.com/trials/determination-of-dose-of-antiangiogenic-multitargeted-dovitinib-tki258-plus-paclitaxel-in-patients-with-solid-tumors-35425https://curecurrent.com/trials/comparison-of-peak-plasmablade-to-conventional-diathermy-in-abdominal-based-free-flap-breast-reconstruction-35426https://curecurrent.com/trials/exercise-programs-in-healthy-young-women-at-increased-risk-of-developing-breast-cancer-35427https://curecurrent.com/trials/acupuncture-and-gabapentin-for-hot-flashes-among-breast-cancer-survivors-35428https://curecurrent.com/trials/effects-of-physical-exercise-on-cardio-vascular-efficiency-and-quality-of-life-in-breast-cancer-survivors-35429https://curecurrent.com/trials/developing-a-new-questionnaire-about-patient-expectations-of-breast-conserving-therapy-35430https://curecurrent.com/trials/palbociclib-in-treating-patients-with-metastatic-her-2-positive-breast-cancer-with-brain-metastasis-35431https://curecurrent.com/trials/anesthesia-and-circulating-tumor-cells-in-breast-cancer-35432https://curecurrent.com/trials/traditional-chinese-medicine-as-preventive-method-for-osteoporosis-induced-by-adjuvant-endocrine-therapy-35433https://curecurrent.com/trials/evaluation-of-virtual-touch-tissue-imaging-quantification-vtiq-2d-swe-in-the-assessment-of-bi-rads-3-and-4-lesions-35434https://curecurrent.com/trials/dc-vaccine-for-patients-with-ductal-carcinoma-in-situ-35435https://curecurrent.com/trials/phase-i-study-of-lurbinectedin-pm01183-in-combination-with-paclitaxel-with-or-without-bevacizumab-in-selected-advanced-s-35436https://curecurrent.com/trials/premenopausal-hormone-concentrations-in-a-population-of-women-at-very-low-risk-of-breast-cancer-35437https://curecurrent.com/trials/the-incidence-of-breast-and-other-cancers-among-female-flight-attendants-35438https://curecurrent.com/trials/prediction-of-pcr-by-preoperative-biopsy-in-breast-cancer-with-ccr-after-neoadjuvant-chemotherapy-35439https://curecurrent.com/trials/partial-breast-radiation-therapy-in-treating-women-undergoing-breast-conservation-therapy-for-early-stage-breast-cancer-35440https://curecurrent.com/trials/study-on-breast-cancer-patient-perspectives-of-exercise-35441https://curecurrent.com/trials/bevacizumab-and-abraxane-as-second-line-therapy-in-triple-negative-metastatic-breast-cancer-35442https://curecurrent.com/trials/hemostatic-profiles-of-endocrine-therapies-for-breast-cancer-35443https://curecurrent.com/trials/a-pilot-study-of-chemo-prevention-of-green-tea-in-women-with-ductal-carcinoma-in-situ-35444https://curecurrent.com/trials/the-effects-of-radiation-in-reconstructed-breasts-35445https://curecurrent.com/trials/anti-her2-therapy-fulvestrant-capecitabine-in-women-with-hr-her2-non-visceral-metastases-stage-iv-breast-cancer-35446https://curecurrent.com/trials/pd0332991-paclitaxel-in-advanced-breast-cancer-35447https://curecurrent.com/trials/acupuncture-in-treating-women-with-stage-i-stage-ii-or-stage-iii-breast-cancer-with-aromatase-inhibitor-related-joint-pa-35448https://curecurrent.com/trials/serratus-plane-block-in-preventing-postoperative-pain-of-mastectomy-35449https://curecurrent.com/trials/cancer-risk-in-x-ray-technologists-second-survey-35450https://curecurrent.com/trials/study-in-post-menopausal-women-with-hormone-receptor-positive-her2-negative-advanced-breast-cancer-35451https://curecurrent.com/trials/phase-i-study-of-oral-bay-1217389-in-combination-with-intravenous-paclitaxel-35452https://curecurrent.com/trials/limited-versus-no-limited-shoulder-movement-in-breast-cancer-surgery-35453https://curecurrent.com/trials/ketorolac-in-breast-cancer-surgery-35454https://curecurrent.com/trials/clinical-evaluation-of-opto-acoustic-image-quality-with-the-gen1b-duplex-probe-in-breast-applications-35455https://curecurrent.com/trials/evaluation-for-the-effectiveness-and-safety-of-cryo-ablation-in-the-treatment-of-early-invasive-breast-cancer-35456https://curecurrent.com/trials/assessment-of-automated-breast-ultrasound-35457https://curecurrent.com/trials/imaging-with-opto-acoustics-to-downgrade-bi-rads-classification-relative-to-other-diagnostic-methodologies-maestro-35458https://curecurrent.com/trials/clinical-utility-study-of-a-low-cost-hand-held-breast-scanner-35459https://curecurrent.com/trials/mild-cognitive-impairment-in-breast-cancer-patients-35460https://curecurrent.com/trials/a-study-to-evaluate-changes-in-human-breast-cancer-tissue-following-short-term-use-of-darolutamide-35461https://curecurrent.com/trials/pink-warrior-support-group-toolkit-for-breast-cancer-survivors-35462https://curecurrent.com/trials/assessment-of-cancer-concerns-at-the-end-of-treatment-ace-35463https://curecurrent.com/trials/bone-mineral-density-in-postmenopausal-women-with-primary-breast-cancer-who-are-receiving-treatment-on-clinical-trial-35464https://curecurrent.com/trials/exemestane-in-reducing-breast-density-in-postmenopausal-women-at-risk-for-breast-cancer-35465https://curecurrent.com/trials/letrozole-in-preventing-breast-cancer-in-postmenopausal-women-who-are-at-increased-risk-for-breast-cancer-due-to-high-br-35466https://curecurrent.com/trials/docetaxel-and-epirubicin-with-and-without-g-csf-in-treating-women-with-metastatic-breast-cancer-35467https://curecurrent.com/trials/tamoxifen-in-treating-women-with-high-risk-breast-cancer-35468https://curecurrent.com/trials/tamoxifen-with-or-without-octreotide-in-treating-postmenopausal-women-with-stage-i-stage-ii-or-stage-iii-breast-cancer-35469https://curecurrent.com/trials/training-with-mobile-application-in-breast-cancer-35470https://curecurrent.com/trials/a-study-of-prexasertib-ly2606368-with-chemotherapy-or-targeted-agents-in-participants-with-advanced-cancer-35471https://curecurrent.com/trials/satisfaction-and-quality-of-life-after-breast-reconstruction-35472https://curecurrent.com/trials/high-dose-chemotherapy-plus-peripheral-stem-cell-transplantation-compared-with-standard-therapy-in-treating-women-with-m-35473https://curecurrent.com/trials/study-of-actr-t-cell-product-in-combination-with-trastuzumab-in-subjects-with-her2-positive-advanced-solid-tumor-cancers-35474https://curecurrent.com/trials/biomarkers-for-breast-cancer-risk-in-african-american-women-35475https://curecurrent.com/trials/individually-tailored-training-prescriptions-in-cancer-patients-the-top-study-35476https://curecurrent.com/trials/safety-and-efficacy-study-of-her2-neu-e75-vaccine-in-breast-cancer-35477https://curecurrent.com/trials/autotaxin-atx-as-a-marker-for-breast-cancer-35478https://curecurrent.com/trials/phase-2-trial-of-pertuzumab-and-trastuzumab-with-weekly-paclitaxel-and-chemotherapy-for-her2-positive-breast-cancer-35479https://curecurrent.com/trials/safety-and-efficacy-study-of-her2-neu-e75-vaccine-in-node-positive-breast-cancer-patients-35480https://curecurrent.com/trials/tumor-immune-mechanism-of-axillary-lymph-node-metastasis-in-early-luminal-type-a-breast-cancer-35481https://curecurrent.com/trials/acute-effect-of-chromatic-environment-during-chemotherapy-35482https://curecurrent.com/trials/bone-mineral-density-and-subsequent-cancer-risk-35483https://curecurrent.com/trials/taxane-induced-peripheral-neuropathy-in-chinese-patients-with-breast-cancer-35484https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-breast-cancer-35485https://curecurrent.com/trials/reducing-breast-cancer-risk-in-korean-american-women-35486https://curecurrent.com/trials/paravertebral-blocks-for-breast-cancer-surgery-35487https://curecurrent.com/trials/effect-of-preoperative-curcumin-in-breast-cancer-patients-35488https://curecurrent.com/trials/prospective-assessment-of-radiation-induced-heart-injury-in-left-sided-breast-cancer-35489https://curecurrent.com/trials/endometrial-changes-in-breast-cancer-women-with-or-without-hormonal-therapies-35490https://curecurrent.com/trials/diagnosis-of-pathological-complete-response-by-vacuum-assisted-biopsy-after-neoadjuvant-chemotherapy-in-breast-cancer-35491https://curecurrent.com/trials/integrative-approaches-to-cancer-survivorship-project-3-35492https://curecurrent.com/trials/health-benefits-of-hit-for-breast-cancer-patients-35493https://curecurrent.com/trials/zoledronate-or-observation-in-maintaining-bone-mineral-density-in-patients-who-are-undergoing-surgery-to-remove-both-ova-35494https://curecurrent.com/trials/study-of-the-response-to-a-neoadjuvant-chemotherapy-based-on-the-antitumor-immune-response-in-localized-breast-cancer-35495https://curecurrent.com/trials/breast-pet-feasibility-35496https://curecurrent.com/trials/capecitabine-and-lapatinib-ditosylate-with-or-without-cixutumumab-in-treating-patients-with-previously-treated-her2-posi-35497https://curecurrent.com/trials/palbociclib-plus-fulvestrant-in-women-with-hormone-receptor-positive-and-human-epidermal-growth-factor-receptor-type-2-n-35498https://curecurrent.com/trials/demographic-clinicopathological-characteristics-and-survival-of-breast-cancer-35499https://curecurrent.com/trials/trial-of-adjuvant-chemotherapy-in-breast-cancer-patients-with-pathological-partial-response-and-complete-response-to-neo-35500https://curecurrent.com/trials/pain-psychological-and-endocannabinoid-responses-to-yoga-in-breast-cancer-survivors-with-chemotherapy-induced-neuropathi-35501https://curecurrent.com/trials/a-clinical-research-of-car-t-cells-targeting-her2-positive-cancer-35502https://curecurrent.com/trials/impact-of-decision-aids-on-breast-cancer-surgery-choice-a-randomized-controlled-trial-35503https://curecurrent.com/trials/phase-ib-trial-of-two-folate-binding-protein-peptide-vaccines-e39-and-j65-in-breast-and-ovarian-cancer-patients-35504https://curecurrent.com/trials/her2-positive-breast-cancer-with-brain-metastasis-gcc-1345-35505https://curecurrent.com/trials/medihoney-for-radiation-dermatitis-35506https://curecurrent.com/trials/assessing-the-efficacy-of-paclitaxel-and-olaparib-in-comparison-to-paclitaxel-carboplatin-followed-by-epirubicin-cycloph-35507https://curecurrent.com/trials/description-of-the-analgesia-obtained-with-the-anesthesiological-protocols-currently-used-in-breast-surgery-35508https://curecurrent.com/trials/magnetic-occult-lesion-localization-and-imaging-molli-35509https://curecurrent.com/trials/exemestane-and-cyclophosphamide-for-metastatic-breast-cancer-35510https://curecurrent.com/trials/early-detection-of-cardiac-damage-with-cmr-in-women-with-breast-cancer-35511https://curecurrent.com/trials/treatment-of-breast-fibroadenoma-with-high-intensity-focused-ultrasound-hifu-35512https://curecurrent.com/trials/comparison-of-contrast-enhanced-spectral-mammography-cesm-to-mri-in-screening-high-risk-women-for-breast-cancer-35513https://curecurrent.com/trials/study-of-pregnancy-hormone-concentrations-in-urban-and-nomadic-mongolian-women-35514https://curecurrent.com/trials/magnetic-resonance-breast-tissue-characterisation-to-improve-risk-stratification-for-breast-cancer-35515https://curecurrent.com/trials/breast-tissue-study-of-breast-diseases-among-women-in-hong-kong-35516https://curecurrent.com/trials/nx-in-luminal-b-breast-cancer-patients-after-neoadjuvant-chemotherapy-35517https://curecurrent.com/trials/cannabis-oil-and-radiation-therapy-for-the-management-of-pain-35518https://curecurrent.com/trials/study-to-investigate-the-effect-of-ab-101-in-breast-cancer-survivors-35519https://curecurrent.com/trials/to-evaluate-efficacy-and-safety-of-hlx10-in-combination-with-chemotherapy-versus-placebo-in-combination-with-chemotherap-35520https://curecurrent.com/trials/collaborative-care-to-reduce-depression-and-increase-cancer-screening-among-low-income-urban-women-35521https://curecurrent.com/trials/laser-therapy-for-vulvovaginal-symptoms-in-breast-cancer-patients-35522https://curecurrent.com/trials/neoadjuvant-run-in-study-with-tak-228-followed-by-letrozole-tak-228-in-women-with-high-risk-er-her2-breast-cancer-35523https://curecurrent.com/trials/neoadjuvant-aromatase-inhibitor-ai-with-ovarian-suppression-versus-chemotherapy-in-premenopausal-breast-cancer-patients-35524https://curecurrent.com/trials/exablate-conformal-bone-system-treatment-of-metastatic-bone-tumors-for-the-palliation-of-pain-35525https://curecurrent.com/trials/effects-of-the-anchor-system-in-the-postural-stability-35526https://curecurrent.com/trials/a-digimed-oncology-pharmacotherapy-registry-35527https://curecurrent.com/trials/yoga-for-breast-cancer-35528https://curecurrent.com/trials/omission-of-surgery-and-sentinel-lymph-node-dissection-in-clinically-low-risk-her2positive-breast-cancer-with-high-her2-35529https://curecurrent.com/trials/metabolomics-explores-biomarkers-for-metastatic-breast-cancer-35530https://curecurrent.com/trials/dibh-proton-planning-35531https://curecurrent.com/trials/multi-media-imagery-program-for-breast-cancer-patients-phase-ii-35532https://curecurrent.com/trials/physical-functional-side-effects-of-taxane-chemotherapy-for-breast-cancer-35533https://curecurrent.com/trials/a-study-to-evaluate-vinorelbine-plus-capecitabine-combined-with-trastuzumab-for-her2-positive-patients-following-neoadju-35534https://curecurrent.com/trials/halaven-post-marketing-surveillance-pms-35535https://curecurrent.com/trials/evaluation-of-the-efficacy-of-estramustine-in-patient-with-breast-cancer-progression-after-treatment-with-aromatase-inhi-35536https://curecurrent.com/trials/study-of-the-functioning-of-prospective-memory-in-breast-cancer-and-the-influence-of-sleep-35537https://curecurrent.com/trials/a-phase-ib-dose-de-escalation-study-with-byl719-in-premenopausal-patients-with-locally-advanced-or-metastatic-breast-can-35538https://curecurrent.com/trials/dose-finding-study-of-bp-c1-in-patients-with-stage-iv-breast-cancer-35539https://curecurrent.com/trials/abraxane-and-lapatinib-in-treating-patients-with-stage-i-stage-ii-or-stage-iii-breast-cancer-35540https://curecurrent.com/trials/integrin-6-targeted-spect-imaging-of-breast-cancer-35541https://curecurrent.com/trials/hormones-and-physical-exercise-hope-study-35542https://curecurrent.com/trials/outcomes-of-the-spanish-cohort-of-early-access-to-pertuzumab-and-trastuzumab-emtansine-35543https://curecurrent.com/trials/using-better-model-sexual-problems-in-breast-cancer-35544https://curecurrent.com/trials/the-effect-of-complex-decongestive-physiotherapy-on-sensory-parameters-in-breast-cancer-related-lymphedema-35545https://curecurrent.com/trials/impact-of-obesity-on-the-efficacy-of-endocrine-therapy-with-aromatase-inhibitors-35546https://curecurrent.com/trials/chronic-pain-and-minor-breast-cancer-surgery-35547https://curecurrent.com/trials/pet-ct-or-pet-mri-in-measuring-tumors-in-patients-undergoing-clinical-imaging-or-with-newly-diagnosed-breast-cancer-35548https://curecurrent.com/trials/a-study-of-trastuzumab-subcutaneous-in-participants-with-human-epidermal-growth-factor-receptor-2-her2-positive-early-br-35549https://curecurrent.com/trials/mindfulness-based-intervention-in-breast-cancer-patients-undergoing-chemotherapy-35550https://curecurrent.com/trials/imaging-with-11c-martinostat-in-breast-cancer-35551https://curecurrent.com/trials/the-radiation-metabolic-signature-of-patient-undergoing-radiotherapy-a-pilot-study-35552https://curecurrent.com/trials/development-of-real-time-image-guided-radiotherapy-35553https://curecurrent.com/trials/technology-and-health-communication-in-improving-health-outcomes-in-patients-scheduled-for-mammography-35554https://curecurrent.com/trials/printed-education-materials-in-patients-who-are-finishing-treatment-for-stage-i-stage-ii-or-stage-iiia-breast-cancer-col-35555https://curecurrent.com/trials/improving-the-approach-to-and-management-of-the-older-metastatic-breast-cancer-patient-35556https://curecurrent.com/trials/an-expanded-access-program-for-am0010-pegilodecakin-35557https://curecurrent.com/trials/exercise-study-for-breast-cancer-survivors-35558https://curecurrent.com/trials/predicted-biomarkers-of-cdk4-6-inhibitors-palbociclib-in-er-positive-metastasis-breast-cancer-35559https://curecurrent.com/trials/dose-escalation-study-in-female-subjects-with-breast-cancer-receiving-aromatase-inhibitor-or-tamoxifen-35560https://curecurrent.com/trials/efficacy-study-of-an-educational-program-for-decision-support-for-breast-cancer-35561https://curecurrent.com/trials/moving-forward-a-weight-loss-intervention-for-african-american-breast-cancer-survivors-35562https://curecurrent.com/trials/individualised-versus-standard-care-for-breast-cancer-patients-at-high-risk-for-chemotherapy-induced-nausea-and-vomiting-35563https://curecurrent.com/trials/adjuvant-6-cycles-of-docetaxel-and-cyclophosphamide-or-3-cycles-of-cyclophosphamide-epirubicin-fluorouracil-followed-by-35564https://curecurrent.com/trials/serratus-plane-plus-pectoral-i-block-versus-serratus-plane-block-for-perioperative-analgesia-in-breast-cancer-surgery-35565https://curecurrent.com/trials/expanded-access-use-of-tucatinib-for-her2-metastatic-breast-cancer-35566https://curecurrent.com/trials/a-study-of-azd2014-in-combination-with-selumetinib-in-patients-with-advanced-cancers-35567https://curecurrent.com/trials/ang1005-in-breast-cancer-patients-with-recurrent-brain-metastases-35568https://curecurrent.com/trials/partial-breast-versus-whole-breast-irradiation-in-elderly-women-operated-on-for-early-breast-cancer-35569https://curecurrent.com/trials/study-of-valproic-acid-vpa-vs-placebo-to-shorten-time-of-indwelling-pleural-catheter-35570https://curecurrent.com/trials/exercise-preconditioning-and-breast-cancer-cardiotoxicity-35571https://curecurrent.com/trials/surveillance-markers-of-utility-for-recurrence-after-neoadjuvant-chemotherapy-for-breast-cancer-35572https://curecurrent.com/trials/temsirolimus-in-treating-patients-with-locally-advanced-or-metastatic-breast-cancer-35573https://curecurrent.com/trials/axillary-reverse-mapping-arm-technique-35574https://curecurrent.com/trials/study-of-tumor-and-blood-samples-from-postmenopausal-women-with-primary-breast-cancer-enrolled-on-clinical-trial-can-nci-35575https://curecurrent.com/trials/intervention-to-hepatic-and-pulmonary-metastasis-in-breast-cancer-patients-35576https://curecurrent.com/trials/a-novel-method-of-clipped-axillary-lymph-node-localization-post-neoadjuvant-chemotherapy-in-breast-cancer-patients-35577https://curecurrent.com/trials/maternal-and-umbilical-cord-hormone-concentrations-in-twin-and-singleton-pregnancies-35578https://curecurrent.com/trials/cognitive-existential-group-therapy-to-reduce-fear-of-cancer-recurrence-a-rct-study-35579https://curecurrent.com/trials/study-comparing-lymphoseek-vs-albumin-nanocolloid-in-head-and-neck-melanoma-and-breast-cancer-35580https://curecurrent.com/trials/pecs-block-in-partial-mastectomy-for-postoperative-pain-control-35581https://curecurrent.com/trials/positive-node-traced-before-neoadjuvant-chemotherapy-nac-35582https://curecurrent.com/trials/safety-and-tolerability-evaluation-study-of-bvac-b-in-patients-with-her2-neu-human-epithelial-growth-factor-receptor-2-p-35583https://curecurrent.com/trials/m5-vs-m6-comparison-study-with-a-sub-study-into-the-dielectric-constant-of-aspirated-cyst-fluid-35584https://curecurrent.com/trials/clinical-high-and-genomic-low-hormone-receptor-positive-early-breast-cancer-patients-with-or-without-adjuvant-chemothera-35585https://curecurrent.com/trials/developing-a-diagnostic-tool-to-predict-response-to-chemotherapy-35586https://curecurrent.com/trials/test-uniformity-of-transdermal-drug-delivery-to-breast-using-diclofenac-epolamine-35587https://curecurrent.com/trials/partial-breast-irradiation-with-chemotherapy-35588https://curecurrent.com/trials/f-18-16-alpha-fluoroestradiol-labeled-positron-emission-tomography-in-predicting-response-to-first-line-hormone-therapy-35589https://curecurrent.com/trials/genetic-characteristics-of-her2-positive-breast-cancer-with-neoadjuvant-tchp-chemotherapy-35590https://curecurrent.com/trials/evaluation-of-the-dcis-score-for-decisions-on-radiotherapy-in-patients-with-low-intermediate-risk-dcis-35591https://curecurrent.com/trials/sentinel-lymph-node-biopsy-with-hybrid-technique-in-breast-cancer-35592https://curecurrent.com/trials/vorinostat-in-treating-women-who-are-undergoing-surgery-for-newly-diagnosed-stage-i-iii-breast-cancer-35593https://curecurrent.com/trials/osteopontin-in-metastatic-breast-cancer-patients-35594https://curecurrent.com/trials/presential-vs-online-group-based-psychosocial-treatment-for-breast-cancer-survivors-35595https://curecurrent.com/trials/everolimus-combined-with-anti-estrogen-therapy-in-hormone-receptor-positive-her-2-negative-advanced-breast-cancer-35596https://curecurrent.com/trials/a-study-to-develop-predictive-and-prognostic-tools-for-optimizing-therapy-with-bevacizumab-frontline-cancer-therapy-in-p-35597https://curecurrent.com/trials/health-and-qol-in-oncological-patients-management-of-bone-pathology-in-italian-citbl-population-35598https://curecurrent.com/trials/trial-of-perioperative-endocrine-therapy-individualising-care-35599https://curecurrent.com/trials/imetx-individualized-metabolic-rx-a-pilot-study-35600https://curecurrent.com/trials/exercise-for-breast-cancer-patients-excap-35601https://curecurrent.com/trials/neosamba-neoadjuvant-does-the-sequence-of-anthracycline-and-taxane-matters-before-or-after-35602https://curecurrent.com/trials/hypaz-hypertension-induced-by-pazopanib-35603https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-receiving-trastuzumab-for-her2-positive-stage-iiib-iv-breast-cancer-35604https://curecurrent.com/trials/evolution-of-the-physical-condition-in-treated-cancer-patients-35605https://curecurrent.com/trials/role-of-contrast-enhanced-spectral-mammography-to-predict-upgrade-rates-of-biopsy-proven-atypical-ductal-hyperplasia-35606https://curecurrent.com/trials/correlation-between-molecular-typing-and-neoadjuvant-chemotherapy-in-breast-cancer-patients-based-on-mammaprint-blueprin-35607https://curecurrent.com/trials/making-activity-time-for-cognitive-health-35608https://curecurrent.com/trials/changes-in-breast-density-and-breast-cancer-risk-in-women-with-breast-cancer-and-in-healthy-women-35609https://curecurrent.com/trials/exergaming-intervention-and-breast-cancer-biomarkers-in-black-women-35610https://curecurrent.com/trials/vaccine-therapy-in-combination-with-rintatolimod-and-or-sargramostim-in-treating-patients-with-stage-ii-iv-her2-positive-35611https://curecurrent.com/trials/activity-cognition-after-treatment-for-breast-cancer-35612https://curecurrent.com/trials/association-of-survival-with-maintenance-therapy-in-patients-with-metastatic-breast-cancer-after-first-line-chemotherapy-35613https://curecurrent.com/trials/false-positive-findings-in-breast-cancer-tomosynthesis-35614https://curecurrent.com/trials/cancer-testis-antigen-immunotherapy-phase-i-study-with-740-cta-vaccinia-virus-35615https://curecurrent.com/trials/delphinus-softvue-roc-reader-study-35616https://curecurrent.com/trials/a-study-of-toca-511-a-retroviral-replicating-vector-combined-with-toca-fc-in-patients-with-solid-tumors-or-lymphoma-toca-35617https://curecurrent.com/trials/compare-daily-ulipristal-acetate-and-combined-oral-contraceptive-effects-on-breast-epithelial-cell-proliferation-35618https://curecurrent.com/trials/using-technology-to-improve-physical-activity-levels-among-postmenopausal-women-the-active-aware-study-35619https://curecurrent.com/trials/study-of-anastrozole-letrozole-or-exemestane-with-or-without-tamoxifen-in-treating-postmenopausal-women-with-hormone-res-35620https://curecurrent.com/trials/pyrotinib-in-breast-cancer-patients-with-poor-response-to-the-neoadjuvant-treatment-of-trastuzumab-and-pertuzumab-35621https://curecurrent.com/trials/aquatic-versus-land-based-exercise-on-lymphedema-post-mastectomy-35622https://curecurrent.com/trials/genetic-characteristics-of-metastatic-breast-cancer-patients-35623https://curecurrent.com/trials/study-to-compare-the-effects-of-azd9496-vs-fulvestrant-in-breast-cancer-35624https://curecurrent.com/trials/implementing-patients-competence-in-oral-breast-cancer-therapy-35625https://curecurrent.com/trials/exablate-mrgfus-treatment-of-metastatic-bone-tumors-for-the-palliation-of-pain-35626https://curecurrent.com/trials/fulvestrant-f-placebo-vs-f-palbociclib-first-line-for-postmenopausal-hormone-receptor-advanced-breast-cancer-35627https://curecurrent.com/trials/pertuzumab-in-first-line-treatment-of-her2-positive-metastatic-breast-cancer-patients-35628https://curecurrent.com/trials/nail-changes-associated-with-chemotherapy-and-prevention-of-nail-pigmentation-by-ice-water-immersion-35629https://curecurrent.com/trials/a-study-on-optimizing-follow-up-for-postmenopausal-women-with-breast-cancer-treated-with-adjuvant-endocrine-therapy-35630https://curecurrent.com/trials/immunogenicity-and-safety-of-dcs-in-breast-cancer-35631https://curecurrent.com/trials/vaccine-plus-montanide-isa-51-and-sargramostim-in-treating-patients-with-stage-iv-breast-cancer-35632https://curecurrent.com/trials/safety-and-pharmacokinetics-of-atezolizumab-combination-treatments-in-participants-with-her2-positive-and-her2-negative-35633https://curecurrent.com/trials/therapy-management-with-nab-paclitaxel-in-daily-routine-35634https://curecurrent.com/trials/capecitabine-plus-pyrotinib-versus-capecitabine-plus-trastuzumab-and-pertuzumab-in-the-first-line-treatment-of-her2-posi-35635https://curecurrent.com/trials/rosuvastatin-to-lower-circulating-tissue-factor-bearing-microparticles-in-metastatic-breast-cancer-35636https://curecurrent.com/trials/serratus-plane-block-vs-erector-spinae-plane-block-on-postoperative-analgesia-in-patients-undergoing-unilateral-breast-s-35637https://curecurrent.com/trials/in-vivo-smart-biopsy-device-protocol-in-radiology-35638https://curecurrent.com/trials/f18-ef5-pet-ct-imaging-in-patients-with-brain-metastases-from-breast-cancer-35639https://curecurrent.com/trials/the-effects-of-anesthetics-on-persistent-pain-following-breast-cancer-surgery-35640https://curecurrent.com/trials/dig-hif-1-pharmacodynamic-trial-in-newly-diagnosed-operable-breast-cancer-35641https://curecurrent.com/trials/promoting-weight-loss-through-diet-and-exercise-in-overweight-women-with-breast-cancer-35642https://curecurrent.com/trials/phase-ii-trial-assessing-the-efficacy-of-immuno-radiation-abscopal-effect-in-patients-with-metastatic-cancers-35643https://curecurrent.com/trials/vicryl-plus-and-monocryl-plus-in-breast-surgery-35644https://curecurrent.com/trials/stereotactic-body-radiotherapy-for-patients-with-breast-cancer-oligometastasis-35645https://curecurrent.com/trials/digital-mammography-computer-aided-breast-cancer-diagnosis-35646https://curecurrent.com/trials/prone-breast-irradiation-for-pendulous-breasts-35647https://curecurrent.com/trials/delphinus-softvue-roc-reader-study-35648https://curecurrent.com/trials/preventive-effect-of-boron-based-gel-on-radiation-dermatitis-35649https://curecurrent.com/trials/capecitabine-in-treating-patients-with-metastatic-breast-cancer-35650https://curecurrent.com/trials/effects-of-a-structured-exercise-program-on-cancer-related-fatigue-in-women-receiving-radiation-therapy-for-breast-cance-35651https://curecurrent.com/trials/a-dose-escalation-study-of-sdx-7320-in-patients-with-advanced-refractory-or-late-stage-solid-tumors-35652https://curecurrent.com/trials/neoadjuvant-paclitaxel-versus-bibf-1120-priming-followed-by-bibf-1120-plus-paclitaxel-in-early-her-2-negative-breast-can-35653https://curecurrent.com/trials/letrozole-and-imatinib-mesylate-in-treating-postmenopausal-participants-with-estrogen-or-progesterone-positive-metastati-35654https://curecurrent.com/trials/stress-diurnal-cortisol-and-breast-cancer-survival-35655https://curecurrent.com/trials/detection-of-circulating-tumor-cells-in-breast-cancer-patients-using-a-novel-microfluidic-and-raman-spectrum-device-35656https://curecurrent.com/trials/post-mastectomy-pain-syndrome-after-preoperative-stellate-ganglion-block-for-breast-cancer-surgeries-35657https://curecurrent.com/trials/experimental-therapeutic-cancer-vaccine-created-in-situ-in-patients-with-stage-ii-stage-iv-cancer-35658https://curecurrent.com/trials/increased-frequency-of-allostim-tm-dosing-in-combination-with-cryoablation-in-metastatic-breast-cancer-patients-35659https://curecurrent.com/trials/pegylated-liposomal-doxorubicin-plus-albumin-bound-paclitaxel-and-trastuzumab-in-her-2-positive-breast-cancer-35660https://curecurrent.com/trials/to-evaluate-the-efficacy-of-ny-eso-1-specific-t-cell-receptor-affinity-enhancing-specific-t-cell-in-solid-tumors-35661https://curecurrent.com/trials/a-statewide-intervention-to-reduce-use-of-unproven-or-ineffective-breast-cancer-care-35662https://curecurrent.com/trials/a-study-of-neoadjuvant-shr6390-in-combination-with-anastrozole-pyrotinib-and-trastuzumab-in-patients-with-er-her2-breast-35663https://curecurrent.com/trials/clinical-study-of-xinmailong-injection-on-reducing-cardiovascular-toxicity-in-adjuvant-chemotherapy-in-breast-cancer-35664https://curecurrent.com/trials/quell-opioid-reduction-and-pain-relief-in-patients-with-cancer-35665https://curecurrent.com/trials/neo-adjuvant-chemotherapy-tac-with-or-without-zoledronic-acid-in-treating-her2-negative-breast-cancer-patients-35666https://curecurrent.com/trials/nicotinic-treatment-of-post-chemotherapy-subjective-cognitive-impairment-a-pilot-study-35667https://curecurrent.com/trials/intensive-medicines-monitoring-study-of-toripalimab-monoclonal-injection-tuoyi-35668https://curecurrent.com/trials/breast-lesion-analysis-for-tomosynthesis-mammography-35669https://curecurrent.com/trials/a-study-of-abemaciclib-ly2835219-in-participants-with-previously-treated-breast-cancer-that-has-spread-35670https://curecurrent.com/trials/8-continuous-vs-8-intermittent-cycles-in-first-and-second-line-in-her2-neu-neg-metastatic-breast-cancer-35671https://curecurrent.com/trials/using-behavioral-economics-to-achieve-improved-healthy-behavior-outcomes-in-breast-cancer-survivors-35672https://curecurrent.com/trials/novel-application-of-indocyanine-green-as-a-biomarker-to-identify-tissue-necrosis-in-mastectomy-patients-35673https://curecurrent.com/trials/study-to-identify-the-impact-of-denosumab-on-the-immune-system-in-patients-with-her2-negative-breast-cancer-35674https://curecurrent.com/trials/monitoring-of-breast-cancers-treated-by-neoadjuvant-therapy-via-diffusion-weighted-magnetic-resonance-imaging-35675https://curecurrent.com/trials/magnetic-resonance-imaging-of-the-whole-body-including-diffusion-in-the-medical-evaluation-of-breast-cancers-at-high-ris-35676https://curecurrent.com/trials/oxybutynin-chloride-in-managing-hot-flashes-35677https://curecurrent.com/trials/exploratory-study-on-therapy-for-breath-hold-in-radiotherapy-35678https://curecurrent.com/trials/phase-ii-study-of-neoadjuvant-weekly-paclitaxel-and-carboplatin-followed-by-dose-dense-epirubicin-and-cyclophosphamide-i-35679https://curecurrent.com/trials/plinabulin-iv-solution-in-prevention-of-tac-induced-neutropenia-35680https://curecurrent.com/trials/oral-cdb-4124-vs-placebo-in-stage-i-ii-primary-breast-cancer-35681https://curecurrent.com/trials/s1008-exercise-diet-counseling-in-improving-weight-loss-in-overweight-female-breast-or-colorectal-cancer-survivors-35682https://curecurrent.com/trials/plant-extracted-natural-compounds-impact-on-stage-iv-breast-cancer-survival-time-and-remission-35683https://curecurrent.com/trials/safety-and-performance-of-the-multi-modal-ultrasound-tomography-must-device-in-breast-cancer-screening-35684https://curecurrent.com/trials/assessment-of-functional-status-of-estrogen-receptors-in-breast-cancer-by-positron-emission-tomography-35685https://curecurrent.com/trials/theory-based-training-to-promote-breast-cancer-screening-35686https://curecurrent.com/trials/autologous-hematopoietic-stem-cell-transplantation-as-adjuvant-treatment-for-triple-negative-breast-cancer-patients-35687https://curecurrent.com/trials/onco4d-tm-biodynamic-chemotherapy-selection-for-breast-cancer-patients-35688https://curecurrent.com/trials/avoiding-sentinel-lymph-node-biopsy-in-breast-cancer-patients-after-neoadjuvant-chemotherapy-35689https://curecurrent.com/trials/weight-gain-prevention-for-breast-cancer-survivors-35690https://curecurrent.com/trials/phase-i-iia-study-of-pharmacokinetics-and-safety-of-epidiferphane-and-taxanes-in-breast-cancer-patients-35691https://curecurrent.com/trials/effectiveness-of-stellate-ganglion-block-in-breast-cancer-related-lymphedema-35692https://curecurrent.com/trials/sunitinib-cyclophosphamide-and-methotrexate-in-treating-patients-with-metastatic-breast-cancer-35693https://curecurrent.com/trials/study-of-bmn-673-with-carboplatin-and-paclitaxel-in-patients-with-advanced-brca-mutated-solid-tumor-or-triple-negative-m-35694https://curecurrent.com/trials/comparing-tapering-low-dose-dexamethasone-to-other-standard-of-care-therapies-for-taps-in-breast-cancer-patients-35695https://curecurrent.com/trials/impact-of-prehabilitation-in-oncology-via-exercise-breast-cancer-35696https://curecurrent.com/trials/e7389-versus-treatment-of-physician-s-choice-in-patients-with-locally-recurrent-or-metastatic-breast-cancer-35697https://curecurrent.com/trials/diagnostic-utility-of-mri-in-female-patients-with-nipple-discharge-a-prospective-trial-35698https://curecurrent.com/trials/study-of-pralatrexate-in-female-patients-with-previously-treated-breast-cancer-35699https://curecurrent.com/trials/vorinostat-in-treating-patients-with-stage-iv-breast-cancer-receiving-hormone-therapy-35700https://curecurrent.com/trials/a-study-to-observe-treatment-patterns-and-outcomes-in-participants-in-saudi-arabia-with-human-epidermal-growth-factor-re-35701https://curecurrent.com/trials/a-clinical-trial-to-compare-efficacy-and-tolerability-of-fulvestrant-250mg-250mg-plus-250mg-loading-regimen-and-500mg-35702https://curecurrent.com/trials/rx-5902-treatment-of-subjects-with-triple-negative-breast-cancer-35703https://curecurrent.com/trials/attitudes-beliefs-and-preferences-of-older-stage-i-iii-breast-cancer-survivors-towards-physical-activity-35704https://curecurrent.com/trials/immediate-breast-reconstruction-with-acellular-dermal-matrix-35705https://curecurrent.com/trials/yoga-for-aromatase-inhibitor-related-knee-pain-relief-in-breast-cancer-patients-35706https://curecurrent.com/trials/clinical-study-on-raman-spectra-of-blood-saliva-and-urine-in-patients-with-cancer-treated-by-modern-therapy-35707https://curecurrent.com/trials/longitudinal-assessment-of-arthralgia-and-related-symptoms-in-breast-cancer-patients-receiving-aromatase-inhibitors-35708https://curecurrent.com/trials/pilot-study-to-evaluate-the-impact-of-denosumab-on-disseminated-tumor-cells-dtc-in-patients-with-early-stage-breast-canc-35709https://curecurrent.com/trials/shr-1210-combined-with-albumin-bound-paclitaxel-and-epirubicin-neoadjuvant-for-triple-negative-breast-cancer-35710https://curecurrent.com/trials/2-arm-trial-of-paclitaxel-plus-bevacizumab-vs-capecitabine-plus-bevacizumab-35711https://curecurrent.com/trials/mithramycin-for-lung-esophagus-and-other-chest-cancers-35712https://curecurrent.com/trials/s0230-goserelin-in-preventing-ovarian-failure-in-women-receiving-chemotherapy-for-breast-cancer-35713https://curecurrent.com/trials/a-multi-histology-phase-ii-study-of-5-fluoro-2-deoxycytidine-with-tetrahydrouridine-fdcyd-thu-35714https://curecurrent.com/trials/safety-and-immunogenicity-study-of-the-new-dher2-vaccine-to-treat-her2-positive-metastatic-breast-cancer-35715https://curecurrent.com/trials/clinical-study-for-the-treatment-of-breast-cancer-the-patient-will-receive-afatinib-plus-letrozole-or-letrozole-alone-35716https://curecurrent.com/trials/postoperative-analgesia-in-breast-cancer-surgery-safety-and-efficiency-of-ultrasound-guided-erector-spinae-plane-block-35717https://curecurrent.com/trials/nurse-driven-telephone-intervention-in-improving-side-effects-in-cancer-patients-undergoing-chemotherapy-35718https://curecurrent.com/trials/an-observational-study-to-register-the-incidence-of-breast-cancer-and-current-clinical-care-patterns-in-kenya-35719https://curecurrent.com/trials/fulvestrant-with-or-without-lapatinib-in-treating-postmenopausal-women-with-stage-iii-or-stage-iv-breast-cancer-that-is-35720https://curecurrent.com/trials/s9313a-protein-expression-analysis-of-breast-cancer-tissue-microarrays-from-clinical-trial-swog-9313-35721https://curecurrent.com/trials/epr-tumor-oximetry-with-ce-india-ink-35722https://curecurrent.com/trials/t-dm1-in-her2-positive-metastatic-relapsed-breast-cancer-35723https://curecurrent.com/trials/paclitaxel-with-trastuzumab-and-lapatinib-in-her2-positive-early-stage-breast-cancer-35724https://curecurrent.com/trials/study-to-evaluate-the-safety-of-nanoxel-m-inj-35725https://curecurrent.com/trials/the-clinical-study-of-modern-therapies-on-flora-in-body-fluids-and-blood-of-malignant-tumor-patients-35726https://curecurrent.com/trials/clinical-trial-of-comparative-study-of-gb221-pharmacokinetics-35727https://curecurrent.com/trials/olaparib-in-combination-with-carboplatin-for-refractory-or-recurrent-women-s-cancers-35728https://curecurrent.com/trials/combination-therapy-of-interleukin-12-and-interleukin-2-to-treat-advanced-cancer-35729https://curecurrent.com/trials/a-pilot-study-of-f-18-paclitaxel-fpac-pet-for-evaluating-drug-delivery-of-solid-tumors-in-breast-lung-renal-and-adrenal-35730https://curecurrent.com/trials/treatment-of-relapsed-and-or-chemotherapy-refractory-advanced-malignancies-by-cart133-35731https://curecurrent.com/trials/analysis-of-data-from-the-women-s-contraceptive-and-reproductive-experiences-care-study-35732https://curecurrent.com/trials/cell-lines-from-high-risk-breast-tissue-35733https://curecurrent.com/trials/patient-preference-for-pegfilgrastim-neulasta-application-forms-35734https://curecurrent.com/trials/motexafin-gadolinium-and-doxorubicin-in-treating-patients-with-advanced-cancer-35735https://curecurrent.com/trials/non-interventional-study-of-the-validation-of-the-ottawa-score-in-cancer-patients-with-venous-thromboembolism-vte-35736https://curecurrent.com/trials/testing-a-spanish-version-of-a-patient-toxicity-questionnaire-35737https://curecurrent.com/trials/the-natural-history-of-solid-organ-cancer-stem-cells-socsc-35738https://curecurrent.com/trials/collection-of-tissue-samples-for-study-of-multidrug-resistance-35739https://curecurrent.com/trials/susceptibility-to-breast-cancer-35740https://curecurrent.com/trials/morbidity-after-diagnosis-and-treatment-of-breast-cancer-patients-35741https://curecurrent.com/trials/effect-of-cancer-nurse-navigators-on-patient-outcomes-35742https://curecurrent.com/trials/the-breast-cancer-online-rehabilitation-program-35743https://curecurrent.com/trials/perillyl-alcohol-in-treating-patients-with-metastatic-breast-cancer-35744https://curecurrent.com/trials/fatigue-intervention-trial-for-breast-cancer-survivors-35745https://curecurrent.com/trials/phase-ii-trial-of-bortezomib-and-doxorubicin-in-metastatic-breast-cancer-35746https://curecurrent.com/trials/ability-of-a-dendritic-cell-vaccine-to-immunize-melanoma-or-epithelial-cancer-patients-against-defined-mutated-neoantige-35747https://curecurrent.com/trials/the-health-of-women-study-35748https://curecurrent.com/trials/a-study-to-evaluate-pertuzumab-trastuzumab-docetaxel-vs-placebo-trastuzumab-docetaxel-in-previously-untreated-her2-posit-35749https://curecurrent.com/trials/enhancing-at-risk-latina-women-s-use-of-genetic-counseling-for-hereditary-breast-and-ovarian-cancer-35750https://curecurrent.com/trials/morbidity-following-the-diagnosis-and-treatment-of-patients-with-breast-cancer-35751https://curecurrent.com/trials/methods-in-education-for-breast-cancer-genetics-35752https://curecurrent.com/trials/pilot-study-of-zirconium-89-bevacizumab-positron-emission-tomography-for-imaging-angiogenesis-in-patients-with-inflammat-35753https://curecurrent.com/trials/follow-up-of-breast-cancer-and-multiple-myeloma-patients-previously-enrolled-in-nih-gene-therapy-studies-35754https://curecurrent.com/trials/xelox-for-metastatic-breast-cancer-35755https://curecurrent.com/trials/evaluation-for-nci-radiation-oncology-branch-clinical-research-protocols-35756https://curecurrent.com/trials/an-open-label-phase-i-study-to-eval-the-safety-and-tolerability-of-a-vaccine-gi-6207-consisting-of-whole-heat-killed-rec-35757https://curecurrent.com/trials/tissue-resistivity-in-breast-cancer-patients-35758https://curecurrent.com/trials/lapatinib-for-brain-metastases-in-erbb2-positive-breast-cancer-35759https://curecurrent.com/trials/nab-paclitaxel-in-patients-with-er-her2-recurrent-metastatic-breast-cancer-35760https://curecurrent.com/trials/e-based-technology-to-provide-decision-aid-on-breast-reconstruction-for-women-with-breast-cance-35761https://curecurrent.com/trials/ly2157299-monohydrate-ly2157299-and-radiotherapy-in-metastatic-breast-cancer-35762https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-clinical-outcome-of-using-fr-mask-in-breast-cancer-patients-with-radiation-irritated-35763https://curecurrent.com/trials/estrogen-for-triple-negative-breast-cancer-35764https://curecurrent.com/trials/accelerated-partial-breast-irradiation-for-early-breast-cancer-35765https://curecurrent.com/trials/virtual-reality-versus-proprioceptive-neuromuscular-facilitation-on-postmastectomy-lymphedema-35766https://curecurrent.com/trials/a-web-based-tailored-health-behavior-intervention-for-breast-and-colon-cancer-survivors-ewellness-35767https://curecurrent.com/trials/efficacy-study-of-single-stage-breast-reconstruction-in-female-participants-with-mastectomy-35768https://curecurrent.com/trials/the-efficacy-and-safety-of-bat8001-injection-for-the-treatment-of-her2-positive-advanced-breast-cancer-35769https://curecurrent.com/trials/evaluation-of-hypertension-as-a-predictor-of-efficacy-bevacizumab-in-metastatic-breast-cancer-and-colorectal-cancer-35770https://curecurrent.com/trials/family-communication-of-hereditary-breast-and-ovarian-cancer-risk-among-african-americans-35771https://curecurrent.com/trials/inpatient-screening-mammography-for-non-adherent-and-high-risk-women-35772https://curecurrent.com/trials/seroma-reduction-after-mastectomy-35773https://curecurrent.com/trials/high-vs-low-dose-dexamethasone-on-complications-in-the-immediate-postoperative-phase-after-mastectomy-35774https://curecurrent.com/trials/nab-paclitaxel-compared-with-docetaxel-followed-by-anthracyclines-and-cyclophosphamide-in-the-neoadjuvant-breast-cancer-35775https://curecurrent.com/trials/a-study-evaluating-the-safety-and-pharmacokinetics-of-abbv-075-in-subjects-with-cancer-35776https://curecurrent.com/trials/accessible-cancer-care-to-enable-support-for-survivors-programme-35777https://curecurrent.com/trials/bone-mineral-density-effects-of-zoledronate-in-postmenopausal-women-with-breast-cancer-35778https://curecurrent.com/trials/fdht-pet-and-bicalutamide-in-metastatic-breast-cancer-35779https://curecurrent.com/trials/a-study-to-evaluate-safety-tolerability-and-efficacy-of-eribulin-mesylate-in-treating-adult-females-with-locally-advance-35780https://curecurrent.com/trials/curcumin-in-combination-with-chemotherapy-in-advanced-breast-cancer-35781https://curecurrent.com/trials/mm-398-nanoliposomal-irinotecan-nal-iri-to-determine-tumor-drug-levels-and-to-evaluate-the-feasibility-of-ferumoxytol-ma-35782https://curecurrent.com/trials/multi-parametric-assessment-of-breast-lymphedema-35783https://curecurrent.com/trials/dose-dense-tc-pegfilgrastim-support-for-breast-cancer-35784https://curecurrent.com/trials/the-new-geneswell-bct-in-vitro-diagnosis-of-breast-cancer-prognosis-35785https://curecurrent.com/trials/a-study-to-compare-pertuzumab-trastuzumab-vinorelbine-vs-placebo-trastuzumab-docetaxel-in-previously-untreated-her2-posi-35786https://curecurrent.com/trials/late-term-effects-of-hypofractionated-chest-wall-and-regional-nodal-irradiation-in-patients-with-breast-cancer-35787https://curecurrent.com/trials/a-phase-i-ii-study-of-abi-007-abraxane-nab-paclitaxel-and-vinorelbine-in-patients-with-stage-iv-metastatic-breast-cancer-35788https://curecurrent.com/trials/genetic-markers-of-circulating-tumor-dna-for-monitoring-breast-cancer-patients-in-costa-rica-35789https://curecurrent.com/trials/abi-007-in-combination-with-bevacizumab-in-women-with-metastatic-breast-cancer-35790https://curecurrent.com/trials/study-of-albumin-bound-paclitaxel-abraxane-in-combination-with-carboplatin-and-herceptin-in-patients-with-advanced-breas-35791https://curecurrent.com/trials/high-dose-chemo-with-autologous-bmt-for-treatment-of-metastatic-breast-cancer-35792https://curecurrent.com/trials/an-innovative-care-improvement-smartphone-based-perioperative-solution-for-women-undergoing-breast-cancer-surgery-35793https://curecurrent.com/trials/study-of-dose-dense-adriamycin-plus-cytoxan-ac-followed-by-either-abi-007-abraxane-or-taxol-with-bevacizumab-as-adjuvant-35794https://curecurrent.com/trials/weekly-vs-every-2-week-vs-every-3-week-administration-of-abi-007-abraxane-bevacizumab-combination-in-metastatic-breast-c-35795https://curecurrent.com/trials/breast-cancer-self-management-mobile-care-application-intervention-in-the-quality-of-life-35796https://curecurrent.com/trials/decision-making-regarding-prophylactic-mastectomy-and-oophorectomy-in-women-seeking-genetic-counseling-and-testing-for-b-35797https://curecurrent.com/trials/first-line-therapy-for-patients-with-metastatic-breast-cancer-35798https://curecurrent.com/trials/does-a-peer-navigator-improve-quality-of-life-at-diagnosis-for-women-with-breast-cancer-35799https://curecurrent.com/trials/denosumab-for-breast-cancer-with-bone-mets-35800https://curecurrent.com/trials/bn83495-phase-i-in-post-menopausal-women-35801https://curecurrent.com/trials/phase-ii-trial-comparing-abi-007-abraxane-nab-paclitaxel-to-taxotere-in-first-line-therapy-of-patients-with-stage-iv-bre-35802https://curecurrent.com/trials/study-of-124i-nm404-in-advanced-solid-malignancies-35803https://curecurrent.com/trials/a-pharmacokinetics-dynamics-ib-study-of-f-627-in-women-with-breast-cancer-receiving-myelotoxic-chemotherapy-35804https://curecurrent.com/trials/assessing-response-to-neoadjuvant-chemotherapy-with-hd-pet-ct-serum-glycomic-markers-and-tissue-muc-1-isoforms-35805https://curecurrent.com/trials/feasibility-of-online-mr-guided-radiotherapy-on-a-1-5t-mr-linac-35806https://curecurrent.com/trials/her2-peptide-vaccination-of-patients-with-solid-tumors-35807https://curecurrent.com/trials/the-recovery-of-reaching-movement-in-breast-cancer-survivors-two-different-rehabilitative-protocols-in-comparison-35808https://curecurrent.com/trials/total-xenoestrogen-body-burden-in-relation-to-mammographic-density-a-marker-of-breast-cancer-rlisk-35809https://curecurrent.com/trials/feasibility-study-of-biomarkers-of-response-to-neoadjuvant-paclitaxel-in-locally-advanced-breast-cancer-35810https://curecurrent.com/trials/survivorship-care-plan-in-promoting-physical-activity-in-breast-or-colorectal-cancer-survivors-in-wisconsin-35811https://curecurrent.com/trials/evaluation-of-prognostic-monitoring-for-women-who-have-completed-standard-treatment-for-breast-cancer-35812https://curecurrent.com/trials/evaluation-of-prognostic-monitoring-for-triple-negative-breast-cancer-patients-35813https://curecurrent.com/trials/a-phase-1b-study-of-tak-700-in-postmenopausal-women-with-hormone-receptor-positive-metastatic-breast-cancer-35814https://curecurrent.com/trials/educational-intervention-for-reducing-work-disability-in-breast-cancer-survivors-35815https://curecurrent.com/trials/component-and-couple-analysis-of-cancer-communications-35816https://curecurrent.com/trials/efficacy-of-preoperative-pectoral-nerve-block-for-intraoperative-opioid-sparing-effect-and-postoperative-analgesia-35817https://curecurrent.com/trials/a-study-to-assess-the-safety-tolerability-and-anti-tumour-activity-of-ascending-doses-of-selumetinib-in-combination-with-35818https://curecurrent.com/trials/evaluation-of-prognostic-monitoring-for-breast-cancer-patients-with-recurrence-and-metastasis-after-surgery-35819https://curecurrent.com/trials/effectiveness-of-the-chess-ehealth-cancer-support-intervention-in-population-based-care-35820https://curecurrent.com/trials/efficacy-and-safety-of-estracyt-in-metastatic-breast-cancer-35821https://curecurrent.com/trials/continuous-pectoral-nerve-block-in-breast-cancer-surgery-35822https://curecurrent.com/trials/evaluation-of-prognostic-monitoring-for-young-breast-cancer-patients-35823https://curecurrent.com/trials/survivorship-care-plans-in-a-community-oncology-practice-35824https://curecurrent.com/trials/grn1005-for-brain-metastases-from-breast-or-lung-cancer-35825https://curecurrent.com/trials/t-cells-in-predicting-acute-graft-versus-host-disease-in-patients-undergoing-donor-stem-cell-transplant-35826https://curecurrent.com/trials/clinical-study-of-recombinant-anti-her2-humanized-monoclonal-antibody-gb221-for-injection-35827https://curecurrent.com/trials/celecoxib-window-of-opportunity-trial-to-assess-tumor-and-stroma-responses-35828https://curecurrent.com/trials/china-cellsearch-study-35829https://curecurrent.com/trials/abi-008-trial-in-patients-with-metastatic-breast-cancer-35830https://curecurrent.com/trials/ki-nect-video-games-based-physiotherapy-programme-in-patients-with-breast-cancer-surgery-35831https://curecurrent.com/trials/preoperative-accelerated-partial-breast-irradiation-for-triple-negative-breast-cancer-using-proton-beam-scanning-35832https://curecurrent.com/trials/neophoebe-neoadjuvant-trastuzumab-bkm120-in-combination-with-weekly-paclitaxel-in-her2-positive-primary-breast-cancer-35833https://curecurrent.com/trials/nuclear-myosin-vi-a-therapeutic-target-in-breast-cancer-35834https://curecurrent.com/trials/an-early-phase-study-of-abraxane-combined-with-phenelzine-sulfate-in-patients-with-metastatic-or-advanced-breast-cancer-35835https://curecurrent.com/trials/gcc-0845-vorinostat-and-lapatinib-in-advanced-solid-tumors-and-advanced-breast-cancer-to-evaluate-response-and-biomarker-35836https://curecurrent.com/trials/importance-of-magnetic-resonance-imaging-mri-in-treating-breast-cancer-35837https://curecurrent.com/trials/opera-for-aromatase-inhibitor-related-arthralgia-management-aia-35838https://curecurrent.com/trials/malm-breast-tomosynthesis-screening-trial-35839https://curecurrent.com/trials/laser-fluorescence-in-cancer-surgical-treatment-35840https://curecurrent.com/trials/adjuvant-dual-anti-her2-therapy-in-patients-with-small-node-negative-her2-positive-breast-cancer-35841https://curecurrent.com/trials/phase-1b-2-trial-using-lapatinib-everolimus-and-capecitabine-for-treatment-of-her-2-positive-breast-cancer-with-cns-meta-35842https://curecurrent.com/trials/acupuncture-for-breast-cancer-related-lymphedema-35843https://curecurrent.com/trials/sentinel-lymph-node-biopsy-in-early-breast-cancer-a-real-world-multicenter-cross-sectional-study-cabs001-study-35844https://curecurrent.com/trials/genetic-counseling-for-breast-cancer-survivors-gc-for-bc-35845https://curecurrent.com/trials/memory-and-thinking-skills-workshop-to-improve-cognition-in-gynecologic-and-breast-cancer-survivors-with-cognitive-sympt-35846https://curecurrent.com/trials/acupuncture-to-prevent-chemotherapy-dose-reduction-due-to-chemotherapy-induced-peripheral-neuropathy-in-breast-and-color-35847https://curecurrent.com/trials/lapatinib-and-trastuzumab-with-or-without-endocrine-therapy-35848https://curecurrent.com/trials/1380gcc-prospective-study-of-gp-88-blood-test-in-healthy-women-with-baseline-gail-model-risk-assessment-undergoing-scree-35849https://curecurrent.com/trials/bms-pd-l1-onco-assessment-of-the-pd-l1-protein-as-a-biomarker-in-oncology-and-hematology-35850https://curecurrent.com/trials/prospective-trial-of-digital-breast-tomosynthesis-dbt-in-breast-cancer-screening-35851https://curecurrent.com/trials/axillary-reverse-mapping-using-methylene-blue-subcutaneous-injection-can-identify-arm-lymph-nodes-and-vessels-measuring-35852https://curecurrent.com/trials/various-g-csf-regimens-to-prevent-infection-during-chemotherapy-35853https://curecurrent.com/trials/pyrotinib-maleate-tablets-combined-with-albumin-paclitaxel-and-trastuzumab-for-her2-positive-breast-cancer-35854https://curecurrent.com/trials/ixabepilone-and-vorinostat-in-treating-patients-with-metastatic-breast-cancer-35855https://curecurrent.com/trials/influence-of-an-intervention-on-diet-physical-exercise-and-mindfulness-in-the-quality-of-life-of-survivors-with-breast-c-35856https://curecurrent.com/trials/study-of-letrozole-with-or-without-palbociclib-pd-0332991-for-the-first-line-treatment-of-hormone-receptor-positive-adva-35857https://curecurrent.com/trials/phase-ii-trial-of-ep4-receptor-antagonist-aat-007-rq-07-cj-023-423-in-advanced-solid-tumors-35858https://curecurrent.com/trials/lmb-9-immunotoxin-in-treating-patients-with-advanced-colon-breast-non-small-cell-lung-bladder-pancreatic-or-ovarian-canc-35859https://curecurrent.com/trials/neoadjuvant-paclitaxel-plus-epirubicin-versus-vinorelbine-plus-epirubicin-in-breast-cancer-with-tekt4-variations-35860https://curecurrent.com/trials/prospective-radiologic-evaluation-of-changes-following-fat-grafting-35861https://curecurrent.com/trials/enzastaurin-plus-fulvestrant-vs-placebo-plus-fulvestrant-in-breast-cancer-35862https://curecurrent.com/trials/novel-biomarkers-and-echocardiography-for-subclinical-cardiac-toxicity-in-breast-cancer-patients-receiving-anthracycline-35863https://curecurrent.com/trials/women-in-steady-exercise-research-formerly-women-oxidative-stress-exercise-and-estrogens-wosee-35864https://curecurrent.com/trials/special-drug-use-surveillance-of-leuprorelin-for-injection-kit-22-5-mg-in-premenopausal-breast-cancer-35865https://curecurrent.com/trials/the-sequelae-of-mastectomy-and-quadrantectomy-respect-to-the-reaching-movement-in-breast-cancer-survivors-35866https://curecurrent.com/trials/broccoli-sprout-extract-in-treating-patients-with-breast-cancer-35867https://curecurrent.com/trials/study-of-avastin-bevacizumab-to-reverse-acquired-estrogen-independence-in-previously-hormone-responsive-metastatic-breas-35868https://curecurrent.com/trials/omega-3-fatty-acid-in-treating-patients-with-stage-i-iii-breast-cancer-35869https://curecurrent.com/trials/multicentric-risk-evaluation-of-autologous-fat-grafting-procedure-35870https://curecurrent.com/trials/a-study-of-tqb2450-injection-and-anlotinib-hydrochloride-capsules-to-treat-triple-negative-breast-cancer-tnbc-35871https://curecurrent.com/trials/vinorelbine-carboplatin-versus-gemcitabine-carboplatin-in-metastatic-breast-cancer-35872https://curecurrent.com/trials/18f-fspg-pet-ct-imaging-in-patients-with-cancers-35873https://curecurrent.com/trials/impact-of-diet-and-physical-activity-changes-on-body-weight-biomarkers-and-quality-of-life-in-breast-cancer-survivors-35874https://curecurrent.com/trials/safety-study-of-pertuzumab-in-combination-with-trastuzumab-and-docetaxel-in-indian-participants-with-breast-cancer-35875https://curecurrent.com/trials/breast-ultrasound-image-reviewed-with-assistance-of-deep-learning-algorithms-35876https://curecurrent.com/trials/the-impact-of-intravenous-anaesthesia-on-angiogenesis-in-patients-with-breast-cancer-tiva-tci-bc-35877https://curecurrent.com/trials/sentinel-node-biopsy-before-and-or-after-neoadjuvant-chemotherapy-in-breast-cancer-35878https://curecurrent.com/trials/acupressure-for-pain-and-opioid-use-among-breast-cancer-patients-35879https://curecurrent.com/trials/intestinal-microbiota-of-breast-cancer-patients-undergoing-chemotherapy-35880https://curecurrent.com/trials/acute-exercise-cardioprotection-from-doxorubicin-35881https://curecurrent.com/trials/pilot-study-for-a-prospective-surveillance-program-for-rehabilitation-following-surgery-for-breast-cancer-35882https://curecurrent.com/trials/ultrasonographic-evaluation-of-changes-after-complex-decongestive-therapy-35883https://curecurrent.com/trials/topical-fluorescent-nanoparticles-conjugated-somatostatin-analog-for-suppression-and-bioimaging-breast-cancer-35884https://curecurrent.com/trials/role-of-sirt1-in-regulation-of-epithelial-to-mesenchymal-transition-in-breast-cancer-lymph-nodes-metastasis-35885https://curecurrent.com/trials/exercise-intervention-in-targeting-adiposity-and-inflammation-with-movement-to-improve-prognosis-in-breast-cancer-35886https://curecurrent.com/trials/responsiveness-of-outcome-scales-in-breast-cancer-related-lymphedema-35887https://curecurrent.com/trials/dietary-restriction-as-an-adjunct-to-neoadjuvant-chemotherapy-for-her2-negative-breast-cancer-35888https://curecurrent.com/trials/safety-and-tolerability-of-recombinant-humanized-anti-pd-1-monoclonal-antibody-for-patients-with-advanced-breast-cancer-35889https://curecurrent.com/trials/supportive-care-questionnaires-in-gathering-data-on-unmet-needs-and-health-related-quality-of-life-in-latina-breast-canc-35890https://curecurrent.com/trials/radiotherapy-in-preoperative-setting-with-cyberknife-for-breast-cancer-35891https://curecurrent.com/trials/study-of-oral-bisphosphonate-for-osteopenic-women-treated-with-adjuvant-aromatase-inhibitors-35892https://curecurrent.com/trials/preoperative-breast-irradiation-35893https://curecurrent.com/trials/azd2281-plus-carboplatin-to-treat-breast-and-ovarian-cancer-35894https://curecurrent.com/trials/efficacy-and-tolerance-study-of-bevacizumab-in-her2-inflammatory-breast-cancer-patients-35895https://curecurrent.com/trials/national-surgical-adjuvant-study-of-breast-cancer-n-sas-bc-07-respect-35896https://curecurrent.com/trials/study-on-skin-microbiome-of-hfs-35897https://curecurrent.com/trials/pembrolizumab-and-monoclonal-antibody-therapy-in-advanced-cancer-35898https://curecurrent.com/trials/docetaxel-carboplatin-trastuzumab-and-lapatinib-in-treating-patients-with-early-stage-breast-cancer-35899https://curecurrent.com/trials/evaluation-of-oral-care-to-prevent-oral-mucositis-in-er-positive-mbc-patients-treated-with-everolimus-phase-3-rct-35900https://curecurrent.com/trials/safety-and-effectiveness-of-mpcd-therapy-on-the-treatment-of-malignant-pleural-effusion-35901https://curecurrent.com/trials/the-consistency-of-drug-screening-in-vitro-and-neoadjuvant-chemotherapy-results-in-breast-cancer-patients-35902https://curecurrent.com/trials/comparison-of-pcr-rate-after-neadjuvant-chemotherapy-guided-by-result-of-in-vitro-cell-culture-drug-sensitivity-or-physi-35903https://curecurrent.com/trials/use-of-metformin-to-reduce-cardiac-toxicity-in-breast-cancer-35904https://curecurrent.com/trials/analysis-of-tumor-tissue-and-circulating-genetic-material-in-the-blood-to-obtain-further-insight-in-the-effectiveness-of-35905https://curecurrent.com/trials/a-phase-2-2-stage-2-cohort-study-of-talazoparib-bmn-673-in-locally-advanced-and-or-metastatic-breast-cancer-patients-wit-35906https://curecurrent.com/trials/stochastic-modulated-vibrations-on-autonomic-nervous-system-of-breast-cancer-patients-during-radiotherapy-35907https://curecurrent.com/trials/humanah-hu3s193-in-the-treatment-of-advanced-breast-cancer-after-hormonal-therapy-35908https://curecurrent.com/trials/bp-c1-monotherapy-in-patients-with-metastatic-breast-cancer-cancer-estimation-of-optimal-duration-of-treatment-35909https://curecurrent.com/trials/genetic-risk-of-osteonecrosis-of-the-jaw-onj-in-patients-with-metastatic-cancer-concordance-study-35910https://curecurrent.com/trials/botulinum-toxin-a-botox-in-tissue-expander-breast-reconstruction-35911https://curecurrent.com/trials/protocol-for-postmenopausal-women-at-increased-risk-of-developing-breast-cancer-35912https://curecurrent.com/trials/fibrotic-focus-in-breast-cancer-35913https://curecurrent.com/trials/bp-c1-in-short-term-treatment-of-patients-with-metastatic-breast-cancer-35914https://curecurrent.com/trials/breast-cancer-recurrence-risk-counseling-35915https://curecurrent.com/trials/anticancer-treatment-of-breast-cancer-related-to-cardiotoxicity-and-dysfunctional-endothelium-35916https://curecurrent.com/trials/chemotherapy-induced-peripheral-neuropathy-could-physical-therapy-help-treat-symptoms-35917https://curecurrent.com/trials/study-of-0-1-uracil-topical-cream-utc-for-the-prevention-of-hand-foot-syndrome-35918https://curecurrent.com/trials/combination-chemotherapy-and-trastuzumab-in-treating-women-with-metastatic-breast-cancer-35919https://curecurrent.com/trials/dibenzyl-trisulphide-guineahen-weed-for-stage-iv-cancer-35920https://curecurrent.com/trials/testing-brca-1-2-mutation-using-next-generation-sequencing-35921https://curecurrent.com/trials/sleep-and-activity-patterns-in-pre-menopausal-breast-cancer-patients-on-tamoxifen-using-a-wrist-worn-internet-of-things-35922https://curecurrent.com/trials/bp-c1-in-short-term-treatment-of-thai-patients-with-metastatic-breast-cancer-35923https://curecurrent.com/trials/estradiol-suppression-for-the-treatment-of-metastatic-breast-cancer-in-premenopausal-women-35924https://curecurrent.com/trials/bp-c1-in-metastatic-breast-cancer-patients-35925https://curecurrent.com/trials/the-analgesic-efficacy-of-the-pectoral-nerves-block-versus-local-anesthetic-infiltration-after-mastectomy-35926https://curecurrent.com/trials/ck19-combined-with-contrast-enhanced-ultrasound-a-prediction-system-on-axillary-lymph-node-metastasis-in-breast-cancer-35927https://curecurrent.com/trials/omitting-biopsy-of-sentinel-lymph-node-with-radiation-after-neoadjuvant-chemotherapy-in-breast-cancer-obserb-trial-35928https://curecurrent.com/trials/pecblock-for-the-treatment-of-pain-after-breast-surgery-35929https://curecurrent.com/trials/18f-fpprgd2-pet-ct-or-pet-mri-in-predicting-early-response-in-patients-with-cancer-receiving-anti-angiogenesis-therapy-35930https://curecurrent.com/trials/mometasone-furoate-0-1-versus-eucerin-on-moderate-to-severe-skin-toxicities-in-breast-cancer-patients-receiving-postmast-35931https://curecurrent.com/trials/4-x-epirubicin-cyclophosphamide-followed-by-4-x-docetaxel-versus-6-x-cmf-6-x-cef-35932https://curecurrent.com/trials/lymphedema-prevention-in-breast-cancer-35933https://curecurrent.com/trials/secondary-adjuvant-long-term-study-with-arimidex-35934https://curecurrent.com/trials/targeted-intraoperative-radiotherapy-targit-registry-database-35935https://curecurrent.com/trials/prospective-thinking-in-hormone-responsive-breast-cancer-35936https://curecurrent.com/trials/breast-capsular-contracture-following-post-mastectomy-reconstruction-in-women-treated-with-the-leukotriene-inhibitor-zaf-35937https://curecurrent.com/trials/diagnosis-of-pathological-complete-response-by-minimal-invasive-biopsy-after-neoadjuvant-chemotherapy-in-breast-cancer-35938https://curecurrent.com/trials/topical-cryotherapy-in-reducing-pain-in-patients-with-chemotherapy-induced-peripheral-neuropathy-or-paclitaxel-induced-a-35939https://curecurrent.com/trials/a-drug-interaction-study-of-necitumumab-imc-11f8-in-combination-with-gemcitabine-cisplatin-35940https://curecurrent.com/trials/effect-of-a-program-of-physical-activity-and-nutritional-therapeutic-education-in-breast-cancer-patients-35941https://curecurrent.com/trials/analysis-of-palbociclib-treatment-in-patients-with-advanced-breast-cancer-within-a-compassionate-use-programe-35942https://curecurrent.com/trials/haplo-allogeneic-nkg2dl-targeting-chimeric-antigen-receptor-grafted-t-cells-for-relapsed-or-refractory-solid-tumour-35943https://curecurrent.com/trials/comparison-between-the-axillary-bilateral-breast-approach-abba-and-bilateral-axillo-breast-approach-baba-for-robotic-thy-35944https://curecurrent.com/trials/clinical-research-of-18f-alfatide-pet-ct-in-breast-cancer-35945https://curecurrent.com/trials/effect-of-ctap101-capsules-on-ca-ipth-in-advanced-breast-prostate-cancer-patients-treated-with-denosumab-zoledronic-acid-35946https://curecurrent.com/trials/intrathecal-trastuzumab-for-leptomeningeal-metastases-in-her2-breast-cancer-35947https://curecurrent.com/trials/study-of-dual-energy-de-contrast-enhanced-ce-digital-mammography-35948https://curecurrent.com/trials/mri-to-detect-breast-tumors-in-women-35949https://curecurrent.com/trials/quantitative-methods-for-supplementing-contrast-enhanced-magnetic-resonance-imaging-of-breast-cancer-35950https://curecurrent.com/trials/mri-for-detecting-cancer-in-women-who-are-at-high-risk-of-developing-breast-cancer-35951https://curecurrent.com/trials/open-label-access-protocol-of-denosumab-for-subjects-with-advanced-cancer-35952https://curecurrent.com/trials/exploring-biological-linkage-between-circadian-disruption-and-cancer-progression-35953https://curecurrent.com/trials/safety-of-toremifene-and-tamoxifen-therapy-in-premenopausal-patients-with-operable-breast-cancer-35954https://curecurrent.com/trials/phase-ii-trial-for-large-er-negative-breast-cancers-35955https://curecurrent.com/trials/fluorescence-imaging-in-sentinel-lymph-node-biopsy-for-breast-cancer-and-melanoma-35956https://curecurrent.com/trials/highly-accelerated-dose-integrated-radiotherapy-in-5-fractions-in-breast-cancer-35957https://curecurrent.com/trials/dynamic-breast-mri-in-assessing-locally-advanced-breast-cancer-35958https://curecurrent.com/trials/sensory-nerve-coaptation-in-diep-flap-breast-reconstruction-35959https://curecurrent.com/trials/study-of-human-epidermal-growth-factor-receptor-2-her2-expression-in-participants-with-early-metastatic-breast-cancer-in-35960https://curecurrent.com/trials/desvenlafaxine-for-treatment-of-hot-flashes-in-women-with-breast-cancer-taking-tamoxifen-35961https://curecurrent.com/trials/trametinib-and-akt-inhibitor-gsk2141795-in-treating-patients-with-metastatic-triple-negative-breast-cancer-35962https://curecurrent.com/trials/comparison-between-levobupivacaine-and-levobupivacaine-with-dexmedetomidine-in-ultrasound-guided-pectoral-nerve-block-35963https://curecurrent.com/trials/awareness-about-breast-cancer-screening-35964https://curecurrent.com/trials/a-phase-trial-of-pyrotinib-combination-with-cdk4-6-inhibitor-shr6390-in-patients-prior-trastuzumab-treated-advanced-her2-35965https://curecurrent.com/trials/lllt-combined-with-cdt-in-breast-cancer-related-lymphedema-35966https://curecurrent.com/trials/tchp-versus-ec-thp-as-neoadjuvant-treatment-for-her2-positive-breast-cancer-35967https://curecurrent.com/trials/intra-individual-comparison-of-conventional-and-digital-pet-ct-scanners-35968https://curecurrent.com/trials/psyhosomatic-medicine-in-oncologic-and-cardiac-disease-study-35969https://curecurrent.com/trials/a-study-of-subcutaneous-at-home-administration-of-trastuzumab-herceptin-in-participants-with-human-epidermal-growth-fact-35970https://curecurrent.com/trials/a-study-of-ly2523355-in-participants-with-breast-cancer-35971https://curecurrent.com/trials/phase-ii-study-of-curcumin-vs-placebo-for-chemotherapy-treated-breast-cancer-patients-undergoing-radiotherapy-35972https://curecurrent.com/trials/xist-gene-deletion-in-breast-cancer-therapy-35973https://curecurrent.com/trials/dhea-in-treating-women-undergoing-surgery-for-stage-i-stage-ii-or-stage-iii-breast-cancer-35974https://curecurrent.com/trials/phase-ii-trial-to-validate-markers-for-a-response-evaluation-of-a-combined-therapy-in-patients-with-her2-breast-cancer-35975https://curecurrent.com/trials/cabergoline-in-metastatic-breast-cancer-35976https://curecurrent.com/trials/prospective-cohort-study-of-traditional-chinese-medicine-for-survival-of-patients-with-early-breast-cancer-35977https://curecurrent.com/trials/social-media-listening-in-improving-clinical-trial-recruitment-in-patients-with-cancer-35978https://curecurrent.com/trials/trial-of-vinflunine-versus-alkylating-agent-in-metastatic-breast-cancer-35979https://curecurrent.com/trials/vitamin-d-supplementation-to-correct-the-vitamin-d-deficiency-for-breast-cancer-35980https://curecurrent.com/trials/recombinant-human-serum-albumin-granulocyte-colony-stimulating-factor-fusion-protein-for-breast-cancer-patients-35981https://curecurrent.com/trials/pyrotinib-combined-with-trastuzumab-plus-aromatase-inhibitor-in-treatment-of-breast-cancer-35982https://curecurrent.com/trials/combination-of-trastuzumab-and-nk-immunotherapy-for-recurrent-breast-cancer-35983https://curecurrent.com/trials/docetaxel-vs-docetaxel-gemcitabine-in-breast-cancer-35984https://curecurrent.com/trials/preoperative-accelerated-partial-breast-irradiation-apbi-for-women-with-stage-i-and-select-iia-breast-cancer-35985https://curecurrent.com/trials/combination-of-cryosurgery-and-nk-immunotherapy-for-advanced-breast-cancer-35986https://curecurrent.com/trials/the-prone-breast-radiation-therapy-trial-35987https://curecurrent.com/trials/zoledronate-in-treating-osteopenia-or-osteoporosis-in-postmenopausal-women-receiving-letrozole-for-stage-i-stage-ii-or-s-35988https://curecurrent.com/trials/study-of-eoc317-in-chinese-patients-with-advanced-solid-tumors-35989https://curecurrent.com/trials/recurrence-score-guiding-chemotherapy-in-non-pcr-hr-positive-her2-negative-breast-cancer-after-neoadjuvant-therapy-35990https://curecurrent.com/trials/feasibility-study-of-meso-biomatrix-device-for-breast-reconstruction-35991https://curecurrent.com/trials/clinical-benefit-of-the-treatment-with-trastuzumab-in-combination-with-lapatinib-in-metastatic-breast-cancer-her2-positi-35992https://curecurrent.com/trials/automated-breast-ultrasound-case-collection-registry-35993https://curecurrent.com/trials/echocardiographic-changes-during-adjuvant-therapy-in-hispanic-women-with-her-2-neu-expressing-breast-cancer-35994https://curecurrent.com/trials/combining-doxycycline-with-bone-targeted-therapy-in-patients-with-metastatic-breast-cancer-35995https://curecurrent.com/trials/impact-of-radiation-therapy-on-breast-conservation-in-dcis-35996https://curecurrent.com/trials/optimizing-decision-making-about-breast-reconstruction-after-mastectomy-a-patient-centered-approach-35997https://curecurrent.com/trials/taxane-acute-pain-syndrome-taps-in-patients-receiving-taxane-chemotherapy-for-breast-or-prostate-cancer-35998https://curecurrent.com/trials/the-breast-cancer-personalized-nutrition-study-35999https://curecurrent.com/trials/computed-tomography-ct-reconstruction-for-axillary-lymph-node-structure-36000